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As well as Ireland’s drugs strategy, the UK’s drug strategy, the EU’s action plan on drugs and the 
UN’s 10-year drug-related targets are all up for review in 2008. 
United Kingdom: new strategy released in February
Ahead of schedule, and following a public consultation process, the fi rst edition of the UK’s new 
drug strategy was released in February 2008.1 Maintaining a single focus on illicit drugs, the new 
strategy places more emphasis than the previous 10-year strategy on families and communities, 
noting that sometimes the individual user has been the focus of too much attention at the expense 
of their family and the wider community. Priority will be given to providing effective treatment 
for those who are causing the most harm to communities and families, e.g. offenders and parents 
whose drug use may be putting their children at risk. Incentives to fully participate in reintegration 
programmes are to be strengthened. For example, the benefi ts system is to be re-engineered to 
support the new focus on reintegration, as it is not deemed ‘right for the taxpayer to help sustain 
drug habits when individuals could be getting treatment to overcome barriers to employment’. 
Ireland: new strategy by end of 2008
In January 2008 Pat Carey TD, Minister of State with responsibility for the Drugs Strategy, described 
the work of the new Steering Group, comprising representatives of the statutory, community 
and voluntary interests involved in tackling problem drug use, which was set up to oversee the 
development of the new strategy for the period 2009–2016. 
Over the coming months, the Group will be examining the progress and impact of the 
current Strategy, the degree to which it continues to be relevant and the operational 
effectiveness of the structures involved. They will also be looking at developments in regard 
to drug policies at EU and international levels. At the conclusion of the process, the Steering 
Group will submit recommendations to me on the shape and direction of the new Strategy.
… a comprehensive public consultation process will be undertaken over the coming months 
as part of the work of developing the new Strategy. Indeed, I intend to be involved directly in 
many of the consultation meetings that are planned. I hope to be in a position to bring the 
new Strategy to the Cabinet Committee on Social Inclusion by the end of this year. 2
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European Union: new action plan by end of 
2008
To support the implementation of the EU Drugs 
Strategy 2005–2012, the European Commission 
prepared an EU Drugs Action Plan 2005–2008. 
The European Commission will carry out an 
impact assessment in 2008 with a view to 
preparing the second action plan for the period 
2009–2012.3 A separate report by Niamh 
Randall, on page 24 of this newsletter, describes 
the discussion with respect to the new EU action 
plan at the fi rst meeting of the EU Civil Society 
Forum on Drug Issues.
United Nations: new targets by mid 2009
In June 1998 the UN General Assembly met 
in a Special Session to address the world 
drug problem. The Session (referred to as 
UNGASS) culminated in the adoption of a 
Political Declaration committing some 150 
states to the achievement of signifi cant and 
measurable results in reduction of illicit supply 
and demand for drugs by the year 2008. Two 
other resolutions were adopted, dealing with 
Guiding Principles of Demand Reduction and 
Measures to Enhance International Cooperation 
to Counter the Drug Problem.
The Commission on Narcotic Drugs (CND), the 
central drug-policy-making body of the UN, is 
responsible for the review of the 1998–2008 
targets. The CND has opted for a two-stage 
process – a review of progress in achieving the 
10-year targets to be undertaken at the March 
2008 CND meeting, and consideration of future 
directions for international drug control policy at 
the March 2009 meeting of the CND.4
This process will be supported by a series of 
meetings on behalf of the CND during the 
course of 2008/09. For example, in July 2008 
NGOs involved in the drugs issue will meet 
in Vienna to refl ect on their achievements in 
drug control over the past 10 years, exchange 
ideas on promising new approaches, reach 
agreements on ways to work together and make 
recommendations to multilateral agencies and 
UN member states on future directions for drug 
control.5
(Brigid Pike)
1. The consultation paper, Drugs: Our 
Community, Your Say, the report on the 
consultation phase, Drugs: Our Community, 
Your Say. A Report on the 2007 Drug Strategy 
Consultation, and the strategy, Drugs: 
protecting families and communities. The 2008 
Drug Strategy, were retrieved on 1 March 
2008 from http://drugs.homeoffi ce.gov.uk. 
See also Pike B (2007) Civil society calls for 
new directions for UK drug policy. Drugnet 
Ireland, Issue 23: 6.
2. Carey P (2008, 30 January) Parliamentary 
Debates Dáil Éireann Offi cial Report: 
Unrevised. Vol. 645, No. 1, pp 413–414, PDF 
version. Retrieved on 7 February 2008 from 
www.gov.ie/oireachtas/frame.htm. 
3. The EU drugs strategy and action plan were 
retrieved on 8 February 2008 from the 
website of the European Monitoring Centre 
for Drugs and Drug Addiction (EMCDDA) 
http://www.emcdda.europa.eu/html.cfm/
index1336EN.html. See also Pike B (2005) 
New EU drugs strategy to add value to 
National Drugs Strategy. Drugnet Ireland, 
Issue 13: 17–18; Pike B (2005) EU action 
plan on drugs 2005–2008. Drugnet Ireland, 
Issue 14: 3.
4. The agenda and briefi ng papers for the 51st 
Session of the CND, to be held in Vienna 
from 10 to 14 March 2008, were retrieved 
on 7 February 2008 from the website of the 
UN Offi ce of Drugs Crime (UNODC) http://
www.unodc.org/unodc/en/commissions/
CND/session/51.html. 
5. For further information, visit the website of 
the Vienna NGO Committee http://www.
vngoc.org/detail.php?id_top=12. See also 
Pike B (2007) Civil society joins international 
debate on drug controls. Drugnet Ireland, 
Issue 22: 3.
‘How effective is the European Monitoring 
Centre for Drugs and Drug Addiction 
(EMCDDA)?’, ‘Is it achieving its tasks and 
goals?’, ‘What benefi ts is it providing for 
the European Union (EU) and its member 
states?’ and ‘Are its activities coherent with 
those launched by the EU institutions in the 
drugs fi eld?’ These were among the questions 
addressed in an independent evaluation of 
the agency, undertaken at the initiative of the 
European Commission, in 2007. The results of 
the year-long exercise were published on the 
EMCDDA website at the end of January 2008.1
According to the evaluators, the EMCDDA is 
‘performing well’ in its core mission to provide 
‘factual, objective, reliable and comparable 
information at European level concerning drugs 
and drug addiction’, i.e., information that is 
needed as an evidence base by policy makers at 
both national and European level. The agency’s 
priority-setting was also found to be ‘closely 
aligned with wider EU policy aims’, such as 
those set in EU drugs strategies and action plans. 
And the EMCDDA was found to be ‘almost 
certainly providing a more cost-effective way of 
monitoring the drugs situation in Europe than 
contents
EMCDDA evaluated
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3In November 2007 Minister of State Pat Carey TD 
outlined his priorities for the new national drugs 
strategy, and invited the views of Dáil deputies. 
The Taoiseach and the Minister for Community, 
Rural and Gaeltacht Affairs were among those who 
contributed their throughts.1
An Taoiseach Bertie Ahern TD emphasised the 
health risks of illicit drug use and the need for 
individuals to take personal responsibility: ‘It is not 
the case that one can just try them [drugs] once or 
twice. The physical and mental health risks are so 
high that an experiment need only go wrong once 
for serious, and sometimes fatal, consequences to 
arise for the drug misuser, their families, friends and 
members of the wider community. …They [drugs] 
are illegal because they are toxic; illegal drugs are a 
serious health risk and must remain illegal for that 
reason. The Government can only do so much. 
Individual citizens must see that there are serious 
physical and mental health risks attached to using 
illegal drugs.’ 
The Minister for Community, Rural and Gaeltacht 
Affairs, Éamonn Ó Cuív TD, reiterated the 
Taoiseach’s emphasis on individual responsibility, 
but went on to argue that the use of heroin and 
other drugs in deprived areas was ‘a slightly 
different issue. Many of these communities have 
suffered serious intergenerational problems, lack 
of opportunity and life expectation and isolating 
the drug problem from the other social issues 
is futile.’ He described how his department had 
been set up to administer a range of community 
programmes, including RAPID, which were 
intended to achieve joined-up thinking in tackling 
the multidimensional problems, including drugs, 
facing such communities. He observed that social 
change is a slow process: a minimum of 20 years 
would be needed before results could be seen on 
the ground.
Minister Carey claimed a particular interest in two 
pillars of the National Drugs Strategy:
Prevention – ‘if we can prevent people starting  ■
a drug habit we can avoid the heartache and 
pain, as well as the expense, that arise as a 
result’; and
Rehabilitation – ‘if we can facilitate people  ■
to become fully involved in the process of 
regaining their capacity for daily life from 
the impact of problem drug use through a 
continuum of care we will, in each individual 
case, achieve a great deal and facilitate a better 
life for many’.
With regard to implementation, Minister Carey 
stressed the importance of inter-agency co-
operation, crossing statutory, community and 
voluntary sectors: ‘Through the new strategy, we 
must ensure that groups work together consistently 
in the coming years to maximise benefi ts. I ask 
everybody to support that as the way forward.’ 
Flexibility and responsiveness in the face of new 
challenges is to be another hallmark. He described 
how the government had responded proactively to 
the emerging problem of cocaine use. In relation 
to the debate over the relationship between drugs 
and alcohol, he stated: ‘I have long been of the 
opinion that the problems of alcohol and illicit drug 
use are interlinked so I will be stressing the need for 
synergy in the approach to these issues.’
Since last autumn Seanad Éireann has debated 
the drugs issue twice, including a motion that the 
Seanad recognise the epidemic of alcohol misuse 
could be undertaken by the Commission itself’.
The EMCDDA’s work was also judged to have had a 
direct impact on EU member states’ drugs policies 
by ‘encouraging a higher degree of coordination 
between them and the adoption of comparable 
structures’. The development across member 
states of harmonised data-collection mechanisms 
‘would not have taken place, at least in the same 
timeframe, without the EMCDDA’, says the report. 
The report points to various ways in which the 
EMCDDA’s performance as information-provider on 
the European drug situation could be enhanced. 
For example, the quality of key indicator data on 
the drugs situation is dependent on the quality of 
the national data gathered, and there is still much 
variation in this area. At present the EMCDDA’s 
data-collection system is ‘only implemented to the 
extent of 60–70% at Member State level’. 
The role and performance of the national focal 
points (NFPs), i.e. the bodies contracted in each 
member state to collect and submit national data 
as requested by the EMCDDA – the Alcohol and 
Drug Research Unit of the Health Research Board is 
the Irish NFP – is discussed. The evaluators found 
that, while there is generally a strong relationship 
between NFPs and their national authorities, the 
relationship between NFPs and politicians and 
political bodies is relatively weak. They linked this 
fi nding to the fact that the role of the EMCDDA 
itself is simply to provide information, rather than 
infl uence decision makers. The evaluation also 
revealed that NFPs enjoy generally satisfactory 
relationships with NGOs, professionals in the drugs 
fi eld and academics, but only a third of NFPs 
reported that their relationship with the media 
‘worked well’.
(Brigid Pike)
1. For a copy of the evaluation report, see http://
www.emcdda.europa.eu/about/evaluation.
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4The National Drugs Awareness Campaign was developed 
and launched in May 2003. The overall aim of the campaign 
was to ‘increase awareness among the general population 
about current problem drug use and its consequences across 
society through the achievement of measurable change in 
the knowledge and attitude of targeted groups’. 
The campaign relied heavily on multi-media components, 
including radio and TV advertising and a website. Live 
roadshows featuring question and answer sessions were 
staged, and booklets, posters and a helpline were developed. 
The campaign slogan, ‘Drugs. There are answers.’, was 
intended to convey a positive message; this approach was 
preferred to one that used scare tactics. 
The National Advisory Committee on Drugs (NACD) 
commissioned a team of external researchers to review 
the development and delivery of the campaign from 2003 
to 2005. The fi nal report of this evaluation was published 
recently.1 This article will highlight the main fi ndings of this 
evaluation and will refl ect on the main learning points that 
emerge which can be used to strengthen future campaigns. 
Sampling strategy and data collection
Purposive sampling was used to select interviewees 
from among those actively involved in the campaign 
development. Those selected included members of the 
Steering Committee, the advertising agency, stakeholders at 
local and regional levels and members of the target groups. 
In total, 94 semi-structured interviews were conducted 
between November 2003 and September/October 2005 
across the three phases of the campaign’s development. In 
addition, documentary material relating to the development 
of the campaign was analysed. 
Key fi ndings of the evaluation
In an extensive review of the literature, the evaluation 
team identifi ed certain criteria to inform best practice in 
developing a drugs awareness campaign. The development 
and implementation of the national campaign were assessed 
against these criteria. 
Theoretical base, aims and objectives: The majority of 
respondents did not consider that any formal theory, model 
or framework had been applied to the development of the 
campaign. The evaluation team point out that the objectives 
set for the campaign, even if they were met, were incapable 
of achieving the stated aim of the campaign. In addition, 
as the campaign developed, key stakeholders reported a 
growing sense of confusion as to what its objectives were.
Target audiences: The interview participants did not perceive 
the target groups to be well defi ned from the start of the 
campaign, and felt the focus to be ad hoc rather than 
planned. 
Multi-component media interventions: The campaign fared 
poorly in this area as the roadshows represented the only 
attempt to bolster the use of multi-media channels with a 
community dimension. 
Message development: According to the evaluators, the 
theme of empowerment conveyed in the campaign slogan 
should have encouraged brand consciousness throughout 
the campaign. However, interviewees reported that they 
failed to recognise this and that there had been a lack of 
coherence to the campaign components. 
Formative evaluation and process evaluation: Formative 
evaluation generally involves pilot-testing campaign 
messages, materials and lines of communication as the 
campaign is being formed. In this case, the development of 
the campaign scored highly as it used formative evaluation 
to assess the roadshows, the cannabis campaign and the 
convenience advertising. The tracking of the development 
of the campaign over three years by a team of external 
evaluators culminated in the fi nal evaluation report 
presented in this article.
The fi ndings of this evaluation suggest that this campaign 
suffered from a lack of coherence, because it did not have 
a specifi c theoretical framework that could have linked 
the various components together and given structure. 
Information awareness campaigns such as this one tend to 
and illegal drug use, especially cocaine, and acknowledge 
the need for a co-ordinated cross-departmental approach 
to the problem.2 With regard to use of the term ‘epidemic’, 
Minister Carey advised that it was important to maintain 
perspective. Senator Ivana Bacik echoed the Minister’s words 
of caution: 
We must be careful of our language when talking 
about drugs and take a rational approach. … There 
is certainly an epidemic of alcohol abuse … We 
must be careful, however, about suggesting there is 
a drugs epidemic, because that suggests the need 
for a crisis response and short-term measures. … It 
behoves us all to look rationally at the issue of drugs 
and seek credible measures to reduce the harm 
associated with drug abuse, and, in particular, to 
reduce and prevent the tragic deaths arising from 
drug abuse.
(Brigid Pike)
1. National Drugs Strategy: Statements (2007, 29 
November) Parliamentary Debates Dáil Éireann Offi cial 
Report: Unrevised. Vol. 642, No 5, PDF version. 
2. National Drugs Strategy: Statements (2007, 17 October) 
Parliamentary Debates Seanad Éireann Offi cial Report: 
Unrevised. Vol. 187, No 8, PDF version; Substance Abuse: 
Motion (2007, 19 December; 2008, 30 January; 2008, 6 
February) Parliamentary Debates Seanad Éireann Offi cial 
Report: Unrevised. Vol. 188, No 5, No 7, and No 9. PDF 
versions.
3. Bacik I (2007, 19 December) Parliamentary Debates 
Seanad Éireann Offi cial Report: Unrevised. Vol. 188, No 5, 
col. 399. PDF version.
The offi cial reports of all Parliamentary debates are available 
at www.gov.ie/oireachtas/frame.htm. 
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5New Drugs Awareness Campaign launched
Mr Pat Carey TD, Minister of State with special responsibility 
for drugs strategy, launched the National Public Awareness 
Campaign on Drugs in the Mansion House in Dublin on 11 
February. The new campaign, funded by the Health Service 
Executive (HSE) and the Department of Community Rural 
and Gaeltacht Affairs, is called ‘The Party’s Over’ and focuses 
on cocaine use.
‘The Party’s Over’ is an integrated public awareness 
campaign comprising several print, online and broadcasting 
initiatives. It includes a website (www.drugs.ie) which 
provides information about drugs and available services and 
Podcasts of discussions on drug-related topics. Visitors to site 
can also have live chats with experts at certain times.
Speaking at the launch, Assistant National Director, 
Population Health, HSE, Catherine Murphy, said: ’Experts 
from the areas of drugs services and health promotion have 
worked together to develop a campaign that will inform 
people about the dangers associated with cocaine use 
while dispelling the myths that exist around the drug.’ The 
organisers of the campaign expressed concern at the results 
of a recent survey of cocaine users in which only one-third 
of those surveyed agreed that cocaine is a highly addictive 
drug, and two in fi ve were not worried about the effect 
the drug might have on their health. The campaign aims 
to highlight the dangers of mixing alcohol and cocaine, 
underline the link between cocaine and crime and increase 
awareness of the personal and fi nancial costs of using 
cocaine.
(Brian Galvin)
be based on an implicit assumption that the target audience 
will react rationally to the messages, and take appropriate 
steps to avoid the consequences inherent in the behaviour 
being highlighted, for example, misuse of drugs. It is 
important that future drugs awareness campaigns learn 
from this evaluation, and that their development is informed 
by meaningful debate and refl ection on the appropriate 
theoretical approach to take. This evaluation contains a 
useful review of the literature on these issues that should be 
used to facilitate this debate. Such a move will contribute 
to an evidence-based approach to what is effective in 
raising awareness about drugs and changing attitudes and 
behaviours associated with their use.
(Martin Keane)
1. Sixsmith J and Nic Gabhainn S (2007) A process evaluation 
of the National Drug Awareness Campaign 2003–2005. 
Dublin: National Advisory Committee on Drugs.
Evaluation of Awareness Campaign (continued)
Ms Catherine Murphy, HSE, Minister Pat Carey, and Mairead Lyons, NACD, at the launch of the Drugs Awareness 
Campaign in the Mansion House (Photo courtesy DAP)
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6This article completes a series of articles in recent issues of 
Drugnet Ireland on the fi rst round of strategic and action 
plans produced by the regional drugs task forces (RDTFs).1 It 
looks at the manner in which the RDTFs address the fourth 
pillar of the National Drugs Strategy – Research.
The importance of research, and the resulting ‘research-
based evidence’, is acknowledged by every RDTF. In some 
instances, research is identifi ed as a strategic objective or 
priority, in others, as an action. The RDTFs note several 
shortcomings in the current provision for research activities. 
Drug-related research is generally conducted by national 
agencies (e.g. the National Advisory Committee on Drugs, 
the Health Research Board, Merchants Quay Ireland, the 
Addiction Research Centre in Trinity College, Dublin, or 
the Drug Treatment Centre Board), focuses on the national 
picture and does not provide detailed local information. 
Even when research is locally based, it tends to be issue-
defi ned rather than geographically determined.
The RDTFs argue that ‘well-conducted, locally-based 
research’ is required, to ensure that resources can be 
allocated effi ciently and effectively within RDTF areas. Calls 
are made for research into, variously:
the extent and nature of the drugs situation in a region  ■
(comparable in one instance to the ESPAD survey) and 
the ability to monitor emerging trends;
the needs of people living in smaller towns and rural  ■
areas, including access to services, and the needs of 
specifi c groups in a region, including homeless people, 
Travellers, lesbian, gay, bisexual and transgender (LGBT) 
people, the parasuicidal, non-Irish-nationals, young 
people, and children affected by problematic drug use;
service-related options, such as the feasibility and options  ■
for introducing harm-related interventions; the feasibility 
of providing residential rehabilitation services for women 
who have young children; facilities available, particularly 
for young people; the optimal means of providing 
treatment in localities adjacent to local drugs task force 
areas.
As well as calling for research to support sound planning, 
a number of RDTFs stress the importance of evaluative 
research. It is viewed as a tool for ‘reviewing and refl ecting 
on practice; … informing further planning and practice; 
sharing and disseminating experiences, learning and good 
practice; being accountable …; making a case for further 
funding’.2 One RDTF also emphasises the contribution that 
research can make to a community development approach 
to the drugs issue:
This [community development] is a two way method 
of working and steps must be taken through the 
development and dissemination of sound and 
meaningful research within the Region to equip 
all stakeholders, community activists, and drug 
workers with accurate and up-to-date research and 
information. In turn, the availability of such research, 
and interpretations of it, will further equip parents, 
teachers, youth workers and young people to address 
drugs with a more comprehensive understanding 
and knowledge of their availability, outcomes, 
prevention techniques and projects, treatment 
methodology and accessibility, and support where 
required.3
The need for adequate funding for research efforts is 
highlighted. One RDTF observes that, in general, funding is 
only allocated to research if it is considered that other drug-
related services are already properly funded and that this 
has led to situations where research activities have remained 
low on the agenda. Furthermore, owing to time and 
resource constraints, ‘evaluation often becomes tacked on 
as “monitoring” which is frequently carried out by already 
stretched project staff who have limited experience in this 
area and very little time available to carry it out’.4
(Brigid Pike)
1. See Pike B (2006) RDTF strategies push out the 
boundaries. Drugnet Ireland, Issue 20: 11–12; Pike 
B (2007) Tools for co-ordinating drugs initiatives in 
the regions. Drugnet Ireland, Issue 21: 6–7; Pike B 
(2007) RDTF strategies and supply reduction. Drugnet 
Ireland, Issue 23: 4; Pike B (2007) RDTF strategies and 
prevention. Drugnet Ireland, Issue 24: 10–11. The RDTFs 
and treatment are considered in an article on page 7 of 
this issue of Drugnet Ireland.
2. East Coast Regional Drugs Task Force (n.d.) Action Plan 
2005–2008, p. 96. 
3. South-East Regional Drugs Task Force (February 2005) 
Strategic Development Plan 2005–2008, pp. 57–8.
4. South-West Regional Drugs Task Force (February 2005) 
Strategy Document, p. 72.
The NACD and drug research in the community and voluntary sectors
The recently published evaluation of the pilot community and voluntary sector research grants scheme funded by the 
National Advisory Committee on Drugs (NACD)1 found that it had been a positive experience for all parties involved. The 
author recommended that the scheme should continue. However, given the relatively high cost of the scheme, she also 
recommended that the NACD should run the scheme in alternate years only, and that it should establish structures at a 
regional level to support the community organisations, funded by developing the grant scheme in partnership with the 
RDTFs and setting up regional research advisory groups.
1. Ennals K (2007) An evaluation of the pilot community and voluntary sector research grant scheme 2001–2005 for the 
National Advisory Committee on Drugs.
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7The regional drugs task forces (RDTFs) are responsible for 
co-ordinating the implementation in the regions of national 
drug policies, as set out in the National Drugs Strategy. 
Previous issues of Drugnet Ireland have looked at the overall 
approach taken by the RDTFs in their fi rst strategic or 
action plans, and their specifi c responses in the areas of co-
ordination, supply reduction and prevention. In this issue the 
responses of the RDTFs under the Treatment and Research 
pillars are examined.1
The RDTFs endorse the approach to drug-related treatment 
set out in the National Drugs Strategy and call for full 
implementation in their regions – including, for example, 
the continuum of care model and the use of key workers; 
the targeting of under-18s; the integration of prison-based 
and community-based treatment services; the provision of 
childcare facilities; and the exploration of alternative medical 
and non-medical treatments. The RDTF strategies also 
endorse the responses to emerging needs identifi ed in the 
Mid-Term Review of the National Drugs Strategy, including 
the need to develop comprehensive rehabilitation services, 
and to provide support services for the parents and families 
of drug users as well as for drug users themselves. 
Some treatment services mentioned in the national 
policy documents are given prominent attention in the 
RDTF strategies, for example, crisis support and point-of-
contact services available at all times; both residential and 
community-based detoxifi cation services; drop-in centres, 
half-way and three-quarter-way houses for respite care; 
and services impacting on the awareness, transmission, 
treatment and management of blood-borne viruses. 
In relation to treatment availability and accessibility, a 
number of RDTFs point out that urban areas may have a 
critical mass of service users concentrated in the one locality, 
resulting in economies of scale for service provision and 
ease of access for users. In rural areas, however, service users 
may be widely scattered in small villages or remote areas, 
without easy access to transport. This poses logistical and 
social challenges in terms of providing services that are both 
accessible to users (either by offering transport to larger 
centres or by providing services locally), and also discreet (in 
order to minimise the risk of stigma). A number of structural 
adjustments are proposed, including one-stop addiction 
assessment and referral points; a standardised treatment 
infrastructure consisting of main treatment centres and 
satellite clinics, with particular emphasis on the network of 
community pharmacies and general practitioners (GPs); and 
greater integration of GP and community-based treatment 
services. 
The possibilities of drug testing, not mentioned in the 
National Drugs Strategy, are discussed. The South-East 
RDTF comments, ‘Those young people most at risk will 
be helped through increased outreach and community 
treatment. They could also benefi t from new initiatives 
including drug testing, referral to innovative and increasing 
treatment facilities, drop-in centres, mentoring and one-
to-one counselling facilities as well as awareness raising 
programmes’.2 The Southern RDTF canvasses the idea that, 
‘With due recognition of the rights of every citizen before 
the Courts, urine samples should be sought from young 
people in this situation and evidence of illegal drugs in the 
system should be taken into account in deciding how best to 
respond to the needs of that person.’
(Brigid Pike)
1. See Pike B (2006) RDTF strategies push out the 
boundaries. Drugnet Ireland, Issue 20: 11–12; Pike 
B (2007) Tools for co-ordinating drugs initiatives in 
the regions. Drugnet Ireland, Issue 21: 6–7; Pike B 
(2007) RDTF strategies and supply reduction. Drugnet 
Ireland, Issue 23: 4; Pike B (2007) RDTF strategies and 
prevention. Drugnet Ireland, Issue 24: 10–11. The RDTFs 
and research is considered in an article on page 6 of this 
issue of Drugnet Ireland.
2. South-East Regional Drugs Task Force (February 2005) 
Strategic Development Plan 2005–2008, p. 56.
3. Southern Regional Drugs Task Force (February 2005) 
Strategic Plan, p. 87. 
4. South-East Regional Drugs Task Force (February 2005) 
Strategic Development Plan 2005–2008, pp. 56–7.
Harm reduction principles on which the South-East 
RDTF predicates its drug strategy 4
Accepts, for better and for worse that licit and illicit 1. 
drug use is part of our world and chooses to work 
to minimize its harmful effects rather than ignore or 
condemn them.
Understands drug use as a complex, multi-faceted 2. 
behavioural phenomenon, ranging between severe 
abuse and total abstinence, and acknowledges that 
some ways of using drugs are safer than others.
Establishes quality of individual and community life 3. 
and well-being – not necessarily cessation of all drug 
use – as the criteria for successful interventions and 
policies.
Calls for the non-judgemental, non-coercive provision 4. 
of services and resources to people who use drugs 
and the communities in which they live in order to 
assist them in reducing attendant harm.
Ensures that drug users and those with a history of 5. 
drug use routinely have a real voice in the creation of 
programs and policies designed to serve them.
Affi rms drug users themselves as the primary agents 6. 
of reducing the harms of their drug use, and seeks 
to empower users to share information and support 
each other in strategies which meet their actual 
conditions of use. 
Recognises that the realities of poverty, class, racism, 7. 
social isolation, past trauma, sex-based discrimination 
and other social inequalities affect both people’s 
vulnerability to and capacity for effectively dealing 
with drug-related harm.
Does not attempt to minimise or ignore the real and 8. 
tragic harm and danger associated with licit and illicit 
drug use. 
RDTF strategies and treatment
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In a recent written answer to a Parliamentary Question, Pat 
Carey TD, Minister of State with special responsibility for the 
Drugs Strategy, outlined the number, size and scale of the 
ten regional drugs task forces (RDTFs) (see Table 1).1 Minister 
Carey explained that expenditure by the RDTFs is building 
up. In 2007 alone it was expected to exceed €7 million, 
and when the RDTFs are fully operational, expenditure will 
be in the region of €14 million per annum. The RDTFs may 
also seek capital funding under the Premises Initiative and 
approximately €0.8 million was allocated for this in 2007.
In a separate written answer on the 12 local drugs task 
forces (LDTFs) in Dublin (excluding Bray and Cork), Minister 
Carey reported their current and capital expenditures, and 
allocations under the Young People’s Facilities and Services 
Fund, for 2005 and 2006 (see Table 2).2
(Brigid Pike)
1. Carey P (2007, 1 November) Parliamentary Debates Dáil 
Éireann Offi cial Report: Unrevised. Vol. 640, cols 1619–21, 
PDF. Available at www.gov.ie/oireachtas/frame.htm. 
2. Carey P (2007, 1 November) Parliamentary Debates Dáil 
Éireann Offi cial Report: Unrevised. Vol. 640, cols 1676–78, 
PDF. Available at www.gov.ie/oireachtas/frame.htm.
Table 2   Dublin LDTFs – current and capital expenditure, and YPFSF funding, 2005 and 2006
Year LDTF Process 
(€m)
Emerging Needs Fund 
(€m)
Premises Initiative Fund 
(€m)
Young People’s Facilities and 
Services Fund (€m)
2005 13.086 0.013 0.452 10.9
2006 12.965 1.803 1.262 10.2
Table 1   RDTFs – catchment areas, current expenditure 2004–2006, approximate population, number of persons whose 
employment is funded by RDTFs
Regional drugs task 
force
Catchment area Expenditure 
2004–2006 
(€m)
Approximate 
population
Number employed 
by RDTF 
(incl. project workers)
ECRDTF East Coast Dún Laoghaire/Rathdown and 
East Wicklow
0.468 188,231 (excl. Bray 
and Dún Laoghaire)
16 (13 project workers)
MRDTF Midland Counties Laois, Longford, 
Offaly, Westmeath
0.210 251,664 4 (1 project worker)
MWRDTF Mid-
Western 
Counties Clare, Limerick, North 
Tipperary
0.437 361,028 7 (4 project workers)
NDRDTF North 
Dublin
North Dublin City and Fingal 0.390 239,992 
(Fingal only)
10 (8 project workers)
NERDTF North East Counties East Cavan, Louth, 
Meath, Monaghan
0.671 362,096 21 (18 project workers)
NWRDTF North 
West 
Counties Donegal, Leitrim, 
Sligo and West Cavan
0.241 269,109 7 (5 project workers)
SRDTF Southern Counties Cork, Kerry (excl. 
Cork City)
0.398 501,754 23 (22 project workers)
SWRDTF South 
West 
South Dublin City, South 
Dublin, County Kildare and 
West Wicklow
0.455 433,270 (Kildare 
and South Dublin)
8 (5 project workers)
SERDTF South East Counties Carlow, Kilkenny, 
South Tipperary, Waterford, 
Wexford
1.437 460,838 26 (26 project workers)
WRDTF Western Counties Galway, Mayo, 
Roscommon
0.501 414,277 12 (10 project workers)
TOTAL 5.208 3,482,259 134 (112 project 
workers)
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outlines the agency’s plans in the drugs and 
alcohol area during 2008.1 The HSE’s Addiction 
Services, including both illicit drugs and alcohol, 
are delivered through Social Inclusion Services, 
which is part of the Primary, Community and 
Continuing Care (PCCC) directorate. Table 1 
overleaf summarises the deliverables identifi ed for 
2008 in respect of illicit drugs and alcohol, together 
with the outputs achieved in 2007. 
The performance targets for Addiction Services in 
2008 have been set as follows:
Percentage of substance misusers for whom  ■
treatment commenced within one month is to 
exceed the 84% level achieved in 2007.
The average number of clients in methadone  ■
treatment per month is to reach 7,000, the 
same level as in 2007.
No target has been set for a third performance 
measure – the number of substance misusers under 
18 years for whom treatment is commenced. 
The NSP explains, ‘Additional staff to support key 
service developments for under-18 services with 
addiction has been identifi ed for 2008. The impact 
of these appointments on current levels of service 
provision will be monitored through our service 
plan reporting.’ 
The focus of the Population Health Directorate 
of the HSE in 2008 will include, among other 
things, further developing, in conjunction with 
the departments of Education and Health, the 
delivery of the Social Personal and Health Education 
(SPHE) programme; further research and education 
initiatives on alcohol in pregnancy; starting a health 
impact assessment project on alcohol off-sales; and 
continuing to work with the Department of Health 
on matters such as alcohol advertising and off-sales. 
The establishment of a unifi ed health system is seen 
as an opportunity to establish new structures and 
mechanisms to promote the reduction of health 
inequalities. The HSE is extending social inclusion 
from its traditional focus on the care and support 
needs of vulnerable groups such as drug users, to 
enhancing the responsiveness of all services at all 
levels of care and thus improving access to health 
services for all service users. Initiatives include:
A new contractual framework for the GMS  ■
and other publicly-funded services involving 
GPs has been developed. One objective is to 
achieve greater responsiveness to the needs 
of vulnerable patients such as the homeless 
or those with addiction problems. In 2008 
this new framework will be signed off on by 
HSE management, and engagement with key 
stakeholders will commence.
A review was completed in 2007 of the current  ■
arrangements for the management of health 
and personal social services provided by the 
non-statutory sector, in recognition of the 
need to develop standardised processes that 
safeguard service users, ensure transparency 
and fairness in the awarding of funding, link 
payments to service levels and outcomes, 
and use formal service level agreements. A 
new management framework was adopted 
and during 2008 this new approach will be 
implemented in the HSE. 
(Brigid Pike)
1. Health Service Executive (2007) National Service 
Plan 2008. Available at www.hse.ie 
Following its tenth Summit meeting, held in Dublin 
on 14 Februry 2008, the British-Irish Council (BIC) 
issued a communiqué regarding drug misuse and 
the family:
Misuse of drugs can have a devastating 
effect on the family. The Heads of 
Administrations discussed the importance 
of supporting families to overcome the 
problems they face and the role families can 
play in the rehabilitation process. 
They refl ected on the impacts of problem 
drug use on families and how these could 
be used in administrations’ development 
of their drugs and/or alcohol strategies. 
They discussed the need to further develop 
advice and guidance for families, and to 
improve support to families in dealing 
with drugs treatment and rehabilitation 
processes. They recognised the importance 
of strategies to reduce the potential harm 
to the children of problem drug users. The 
Council also considered ways to utilise the 
potential of families as agents for drug use 
recovery. 
The Council agreed to include a renewed 
focus on the families of problem drug users 
in any future drugs strategies prepared, 
with a view to providing increased support 
to those families and to better harness their 
potential to facilitate life improvements for 
problem drug users.
For further information on the British–Irish Council 
and its work in the drug policy domain, visit www.
british-irishcouncil.org.
(Brigid Pike)
HSE outlines plans for drug and 
alcohol services in 2008
Drug misuse and the family 
discussed at BIC meeting
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HSE outlines plans (continued)
Table 1   Addiction Services in 2008 (after HSE NSP 2008: 51–52)
Focus Outputs 2007 Deliverables 2008
National Drugs Strategy
The National Drugs Strategy 
comes to an end in 2008 and is 
being reviewed. The Department 
of Community, Rural and 
Gaeltacht Affairs is currently 
establishing a structure for this 
review. The HSE will have a 
critical role to play in this.
Participate in review of the 
National Drugs Strategy.
Cocaine treatment
National co-ordinator employed 
to lead the National Addiction 
Training Programme, with initial 
emphasis on cocaine training.
Implementation of the National 
Addiction Training Programme 
progressed.
Development of treatment 
services for under-18s Primary notifi cation in place 
for multidisciplinary team 
enhancement and developments.
Development of multidisciplinary 
team enhancements and related 
services.
Data collection
The provision of robust 
information to underpin service 
planning in drug and alcohol 
services is a priority for Social 
Inclusion services.
Glossary agreed with the Health 
Research Board (HRB). Mapping 
completed and gaps identifi ed 
in data-collection systems from 
treatment services.
Examination and reconfi guration 
of performance indicators for 
drug and alcohol. Mapping of 
data collection systems.
Health Atlas
The Health Atlas aims to enable 
web-based mapping of health 
related data on a national basis.
Mapping services completed 
and framing of 4-tier model 
progressed to Health Atlas.
Drug and alcohol information 
input to Health Atlas.
Quality initiatives / standards
Quality in alcohol and drug 
services (QUADS) and Drug and 
Alcohol Occupational Standards 
(DANOS) are benchmarking 
standards for the drug and 
alcohol service.
QUADS / DANOS accepted as the 
benchmarking standards.
Use of QUADS mapped around 
the country.
Ramifi cations for implementing 
DANOS explored.
Drugs task force mainstreaming
The Department of Community, 
Rural and Gaeltacht Affairs has 
funded a number of drugs task 
force pilot projects.
Working group established to 
plan mainstreaming of drugs task 
force projects.
Mainstreaming proposal 
document developed.
Review under way of the list of 
projects to ensure they are in line 
with HSE policy.
Process agreed with DCRGA and 
DOHC to manage mainstreaming 
of the National Drugs Strategy 
projects that have been 
evaluated.
Project-by-project analysis of 
drugs task forces undertaken. 
Projects mainstreamed.
Links to HSE Working Group on 
Alcohol Cross-directorate process 
established with Offi ce of the 
CEO, Primary, Community and 
Continuing Care, and National 
Hospitals Offi ce.
Cross-directorate strategic focus 
on alcohol developed.
Best-practice guidelines for the 
alcohol services developed.
National Drugs Rehabilitation 
Strategy
Rehabilitation is a key priority in 
2008.
National Drugs Strategy report 
on rehabilitation completed.
Drug Rehabilitation 
Implementation Committee 
developed.
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Trends in treated problem alcohol 
use, 2004–2006
On 18 March 2008, the Health Research Board 
published preliminary trends in treated problem 
alcohol use based on data reported to the National 
Drug Treatment Reporting System (NDTRS).1 A 
total of 16,020 cases were treated for problem 
alcohol use in Ireland between 2004 and 2006. It is 
important to note that the reporting system collects 
data on episodes of treatment, rather that the 
number of individual people treated each year. This 
means that individuals may appear more than once 
if they attend more than one treatment service in a 
year, and may reappear in subsequent years.
Of the cases treated for problem alcohol use 
between 2004 and 2006, 59% entered treatment 
for the fi rst time. There was a 21% increase in the 
number of new cases during the reporting period. 
The increase in numbers could be explained by 
an increase in problematic alcohol use in the 
population, an increase in the number of service 
providers reporting treated cases to the NDTRS, or 
a combination of these two factors.
Between 5,000 and 5,500 cases were treated 
each year and reported to the monitoring system. 
It is essential to point out that the collection of 
treatment fi gures for alcohol is still in the initial 
stages and that not all alcohol treatment services 
provided information for the three-year period 
under review. This means that the fi gures presented 
are an underestimate of the true extent of treated 
alcohol use in Ireland and refl ect the degree of 
participation in the reporting system by treatment 
services, rather than the actual levels of treatment 
required or, indeed, provided in any one region. 
For example, participation by services in the 
East (Wicklow, Kildare and Dublin) and the West 
(Galway, Mayo and Roscommon) is still incomplete. 
Of note, one in fi ve new cases treated for alcohol 
as a main problem substance reported a problem 
with one or more other drugs. Cannabis (16%), 
cocaine (7%), ecstasy (7%) and amphetamines 
(2%) were the four most common additional 
problem drugs reported. The number of new cases 
receiving treatment for problem use of both alcohol 
and cocaine increased by 40% in the three-year 
period, although the overall number of such cases 
is still low. Research has shown that the use of 
these two drugs together results in the formation 
of cocaethylene, which potentiate the cardiotoxic 
effects of cocaine alone. Taking cocaine and 
alcohol together can also increase the likelihood of 
violent thoughts, which can in turn lead to violent 
behaviour. 
Of the alcohol cases treated for the fi rst time, 68% 
were men; one-third were unemployed; and 2.5% 
were homeless. New cases treated for problem 
alcohol use combined with one or more other 
problem drugs were more likely to be men, under 
18 years of age, homeless and unemployed than 
those treated for problem alcohol use only. 
In line with the growing number of people of other 
nationalities living in Ireland, there was an increase 
in the number of non-nationals treated for problem 
alcohol use during the reporting period. 
The NDTRS records the treatment intervention(s) 
provided when the client is fi rst admitted to a 
treatment service. Counselling was the most 
common initial treatment intervention in 2006 
and was recorded for over three-quarters (77%) 
of all treated cases. This was followed by alcohol 
detoxifi cation, which was provided to 28% of cases, 
and education awareness programmes provided 
to 25% of cases. Approximately one in fi ve treated 
cases received medication-free therapy (23%), 
family therapy (21%) or brief intervention (20%). 
(Jean Long)
1. Fanagan S, Reynolds S, Mongan D and Long J 
(2008) Trends in treated problem alcohol use in 
Ireland, 2004 to 2006. Trends Series 1. Dublin: 
HRB. Available at www.hrb.ie.
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Eurobarometer 37.011 was conducted in 1992 and 
contained questions about alcohol use. The basic 
sample design applied to all member states was 
a multi-stage, random one. All interviews were 
conducted face-to-face in people’s homes. The 
National Health and Lifestyle Survey (SLAN) was 
fi rst undertaken in 19982 by the National University 
of Ireland, Galway, and repeated again in the 
summer of 2002.3 In both rounds, a representative 
cross-section of the Irish adult population was 
surveyed by post, with a section of each survey 
devoted to alcohol use. On both occasions a 
national sample was generated randomly from the 
Irish electoral register. 
Eurobarometer (1992) had 1,877 valid respondents 
aged 18 years or over, SLAN (1998) had 6,370 and 
SLAN (2002) had 5,931. Respondents’ average 
alcohol intake was measured in units of alcohol 
typically imbibed in one week. One unit of alcohol 
was calculated as a half pint of beer, lager, stout or 
cider, a single measure of spirits or a single glass of 
wine, sherry, port or premixed drinks. Abstainers 
represented 39% of the overall sample population 
in 1992, 17% in 1998 and 16% in 2002. The 
abstainers in 1992 were 48% women (454) and 
30% men (274); in 1998, 19% women (622) and 
14% men (400); and in 2002, 17% women (581) 
and 15% men (349). 
Respondents who consumed at least one unit of 
alcohol a week represented 61.2% (1,149) of the 
sample population in 1992, 53.7% (3,418) in 1998 
and 48.6% (2,885) in 2002, and are therefore well 
represented for the purpose of secondary analysis. 
Table 1 details the average number of units, by type 
of alcohol, consumed per week by respondents 
in the three survey periods. The mean range of 
values is used to report average consumption, as 
different methods were employed to collect data 
for Eurobarometer and for SLAN. A statistically 
signifi cant increase or decrease in consumption can 
be said to occur if no overlap exists between the 
mean ranges reported for consecutive survey years. 
In all three survey years, respondents who drank 
beer had the highest weekly alcohol intake, while 
wine drinkers reported the lowest levels. The increase 
in weekly consumption between 1992 and 1998 is 
signifi cant for every alcohol type, with beer drinkers 
showing the greatest increase, imbibing 9.0–9.6 
units of alcohol more per week in 1998 than in 
1992. Wine drinkers showed the second highest 
increase in average weekly consumption over this 
period, at 5.8–6.3 units. Consumers of spirits showed 
the smallest increase, at 4.3–4.8 units.
It must be noted that there are limits to the extent 
to which the Eurobarometer and SLAN data typify 
the level of alcohol use in Ireland. Neither survey 
was designed to collect information specifi cally on 
alcohol use, and results may have been infl uenced 
by methodological differences, such as sampling 
frame, item wording, and method and timing of 
data collection. The Eurobarometer survey reported 
a much higher response rate than either of the 
SLAN surveys, possibly because it was administered 
through face-to-face interviews rather than by post. 
Nevertheless, both surveys offer some insights into 
trends in alcohol consumption in Ireland from 1992 
to 2002.
(Aileen Connor)
1. Eurobarometer 37.01 merges the responses to 
identical questions from two Eurobarometer 
surveys, Eurobarometer 37.0: Awareness and 
importance of Maastricht and the future of the 
European Community, March-April 1992 and 
Eurobarometer 37.1: Consumer goods and 
social security, April-May 1992. Brussels: INRA 
(Europe). Available at http://www.ucd.ie/issda 
2. SLAN (1999) The National Health and Lifestyle 
Surveys. Centre for Health Promotion Studies, 
NUI, Galway and Department of Health and 
Children.
3. SLAN (2003) The National Health and Lifestyle 
Surveys. Centre for Health Promotion Studies, NUI, 
Galway and Department of Health and Children.
Alcohol consumption patterns 
1992–2002
Table 1   Current drinkers’ alcohol consumption pattern and average units consumed weekly, by type 
of alcohol
Eurobarometer 1992 SLAN 1998 SLAN 2002
Alcohol type Number 
(%) of 
current 
drinkers
Average 
units per 
person per 
week
Number 
(%) of 
current 
drinkers
Average 
units per 
person per 
week
Number 
(%) of 
current 
drinkers
Average 
units per 
person per 
week
All 1149 7.0–7.3 3418 13.9–14.4 2885 13.3–13.7
Beer 898 (78.2%) 7.5–7.8 2488 (73%) 16.6–17.4 1659 (58%) 16.1–17.0
Spirits 528 (46.0%) 6.9–7.4 769 (23%) 11.2–12.1 706 (25%) 11.9–12.8
Wine 231 (20.1%) 4.8–5.3 1009 (30%) 10.7–11.5 1233 (43%) 10.8–11.5
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Advisory group to examine laws on sale of 
alcohol
On 9 January, the Minister for Justice, Equality and 
Law Reform, Mr Brian Lenihan TD, announced that 
the Government had approved his proposal to set 
up an advisory group to examine key aspects of 
the law governing the sale and consumption of 
alcohol. The group, to be chaired by Dr Gordon 
Holmes, will report to the Minister by 31 March 
2008, enabling legislation to be enacted before the 
summer recess. 
The group has been established against a 
background of a 17% increase in alcohol 
consumption in the past decade. In addition, there 
has been a 35% increase in the number of off-
licenses between 2003 and 2005 (up from 785 to 
1,070) and an increase of 20% in the number of 
premises with wine-only licences.
The issues to be examined by the group are:
The increase in the number of supermarkets,  ■
convenience stores and petrol stations with off-
licences and the manner and conditions of sale 
of alcohol products in such outlets, including 
below-cost selling and special promotions;
The increasing number of special exemption  ■
orders which permit longer opening hours 
being granted to licensed premises around the 
country; and
The use, adequacy and effectiveness of existing  ■
sanctions and penalties, particularly those 
directed towards combating excessive and 
underage consumption.
Minister Lenihan stated that, in parallel with  ■
this initiative, work would continue on drafting 
the Sale of Alcohol Bill, which is included in the 
government’s legislation programme for 2008. 
This Bill will modernise and streamline the laws 
relating to the sale and consumption of alcohol. 
Alcohol to carry health labels
Drinks Manufacturers of Ireland (DMI), the 
representative body for the alcohol beverage 
manufacturing sector, has reached agreement 
with government and the other social partners 
to introduce a mandatory system of labelling on 
alcoholic drinks sold in Ireland. 
The industry has agreed to introduce labels that 
will specify the amount of alcohol in a product, 
and will include guidelines for sensible drinking. 
The labelling will also feature information advising 
women on the dangers of drinking alcohol while 
pregnant. It is hoped that the labels will convince 
pregnant women that it is in the best interests of 
their unborn child not to consume any amount 
of alcohol while pregnant. The aim of the health 
warnings is to ‘caution women of the dangers 
of consuming alcohol while pregnant’ and to 
create a more health conscious society where 
consumers ‘keep within sensible guidelines’ 
and make ‘informed choices about their alcohol 
consumption’. The government will now have to 
draft the necessary legislation to give effect to the 
agreed changes. 
Drink driving limit to remain unchanged for at 
least another 18 months
The Road Safety Strategy 2007–2012 published in 
October 2007 recommends lowering the drink-
drive limit by June 2009, but does not suggest 
what that limit should be. According to Minister 
for Transport Noel Dempsey, an advisory panel 
will make recommendations on a reduced blood 
alcohol concentration (BAC) limit early in 2008, 
and the new limit should be in place ahead of the 
deadline of June 2009 contained in the Strategy. 
Ireland and the UK have a BAC limit for drivers of 
80mg/100ml, while all other European countries 
have moved to a 50mg/100ml limit. Alcohol is 
estimated to be a contributory factor in 37% of 
all fatal crashes in Ireland, and 90% of the drivers 
involved in these cases were male. Alcohol is a 
factor in half of all fatal crashes involving males 
aged under 35 years. Speaking at the launch of the 
Strategy, Mr Dempsey stated that he, personally, 
was in favour of a move from the current level of 
80mg/100ml to 50mg/100ml.
(Deirdre Mongan)
Initiatives on alcohol
In December 2007 Scottish Health Action on 
Alcohol Problems (SHAAP) published the fi ndings 
of an expert workshop convened in September 
2007 to consider possible government action on 
pricing policy to reduce alcohol-related harm in the 
population.1
Alcohol-related morbidity and mortality are 
increasing in the UK. Between 1991 and 2004 the 
number of alcohol-related deaths almost doubled. 
Over the past 30 years, liver cirrhosis mortality has 
risen by over 450% across the population, as well 
as peaking at a younger age. In Scotland, there was 
a 52% increase in alcoholic liver disease between 
1998 and 2002. According to the Scottish Health 
Survey in 2003, 27% of men and 14% of women 
reported drinking more than the recommended 
weekly limits. Alcohol-related problems are 
estimated to cost Scotland over one billion pounds 
every year. 
Review of policy on alcohol pricing 
in Scotland
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In the past 40 years, alcohol consumption in the UK 
has doubled, rising from 5.7 litres of pure alcohol per 
person aged 16 or over in 1960 to 11.3 litres in 2005. 
Another signifi cant change in recent years is the shift 
away from drinking outside the home to drinking at 
home. Sales by the off-trade sector now account for 
nearly half of all the alcohol sold in the UK.
Alcohol is price sensitive, and research shows 
that an increase in price will lead to a decrease 
in consumption, and vice versa. Even though the 
sale price has increased, the real price of alcohol 
has been in steady decline. Because households’ 
disposable income had increased by 97% in real 
terms, alcohol was 62% more affordable in 2005 
than in 1980. Competition between sellers of 
alcohol has also driven down prices. In 2007, 10 
grocery retailers, including Tesco, Aldi and Lidl, 
reported to an inquiry by the UK Competition 
Commission that they sold alcohol below cost, 
and used temporary promotions as a means of 
attracting customers into the store and increasing 
total sales. Supermarkets accounted for more than 
60% of the volume of alcohol sold in the off-trade 
market in 2006. 
Alcohol policy has tended to focus on the minority 
of the drinking population who are the heaviest 
drinkers. In reality, it is the much greater number 
of drinkers in a population who drink to excess on 
occasion that accounts for most of the alcohol-
related problems. A Finnish study revealed that the 
majority of problems were found in the 90% of the 
population who were moderate consumers, rather 
than in the 10% who drank heavily.2 
The World Health Organization has stated that 
the most effective alcohol policies include alcohol-
control measures (price and availability), drink-
driving laws, and brief interventions for hazardous 
and harmful drinkers. In the UK, by contrast, 
strategies aimed at reducing escalating levels of 
alcohol-related harm have focused predominantly 
on specifi c groups of ‘problem’ drinkers, identifi ed 
as under-18s and young ‘binge drinkers’. A 
strategy which targets only these groups, without 
addressing the wider drinking culture and 
environment, ignores the fact that young people do 
not form their views and attitudes towards alcohol 
use in isolation, but are infl uenced by their parents’ 
drinking habits and the culture of drinking in their 
own area. The UK strategies also rely heavily on 
policies with the weakest evidence base – education 
and voluntary regulation by the alcohol industry 
– in attempting to effect change. They are further 
undermined by action taken by government to 
relax controls on the supply of alcohol. Alcohol is 
now available in more places, for longer periods, 
and at more affordable prices.
A lot of emphasis in UK alcohol strategies is placed 
on individual responsibility for appropriate drinking 
behaviour, with some commentators arguing 
that alcohol consumption is entirely a matter of 
individual responsibility, not an area to be regulated 
by government intervention. Harmful alcohol use 
is rarely, if ever an ‘individual’ problem; it impacts 
on family, friends, work colleagues, and ultimately 
society as a whole. 
The SHAAP report advocates using price as a lever 
to reduce alcohol consumption and related harm. 
Based on estimates by the Academy of Medical 
Sciences, a 10% rise in alcohol price would save 
the lives of 479 men and 265 women in Scotland 
each year. The report recommends that the Scottish 
government:
Ends irresponsible alcohol promotions in all  ■
licensed premises 
Establishes minimum prices for alcoholic drinks  ■
Makes representation to Westminster (a) to  ■
increase alcohol duty and link alcohol taxes to 
infl ation, and (b) to link levels of taxation to 
alcohol strength
Reconvenes the National Licensing Forum with  ■
appropriate health representation
Considers whether there is a need to create an  ■
independent, regulatory body to protect the 
health of the nation in relation to alcohol
Considers jointly initiating a Parliamentary  ■
inquiry into the health and social harm caused 
by alcohol in Scotland. 
While this report concentrates on Scotland, many 
of the issues addressed are relevant to the current 
situation in Ireland, where the rise in alcohol 
consumption in the past decade has coincided 
with an increase in alcohol-related morbidity and 
mortality. There has been a shift from drinking in 
licensed premises to drinking at home, and the real 
price of alcohol has fallen, particularly in the off-
trade sector. In its efforts to reduce alcohol-related 
harm in Ireland, the government should consider 
introducing policy measures similar to those 
recommended in this report.
(Deirdre Mongan)
1. Gillan E and Macnaughton P (2007) Alcohol: 
price, policy and public health. Edinburgh: 
Scottish Health Action on Alcohol Problems 
(SHAAP).
2. Poikolainen K, Paljärvi T and Makela P (2007) 
Alcohol and the preventive paradox: serious 
harms and drinking patterns. Addiction, 102: 
571–578.
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Minister of State Pat Carey TD launched a client 
evaluation study of the Keltoi treatment centre in 
Dublin on 12 November 2007.1 Funded by the 
Health Service Executive, the study was a cross-
sectional survey of a sample of clients who had 
been discharged between one and three years prior 
to interview. 
The treatment model employed by Keltoi is unique 
in Ireland. It is based on international fi ndings that 
rehabilitation with a focus on developing new 
living skills produces more favourable outcomes. 
According to Keltoi, a favourable outcome sees 
clients developing and successfully maintaining a 
drug-free lifestyle.
Of the 485 clients referred to Keltoi between 2002 
and 2004, 149 (31%) were treated. Ninety-fi ve 
per cent of clients admitted to the treatment 
programme had severe opiate dependence 
problems, and a small proportion had severe 
cocaine dependence. To be admitted to the 
programme, clients had to be drug-free for two to 
six weeks, depending
on the individual case and the assessment of the 
team. Ninety-two participants (62%) agreed 
to be interviewed, two of whom died prior to 
the interview date. Eighty questionnaires were 
completed. The fi nal sample comprised 52 (74%) 
men, 18 (26%) women and 10 individuals whose 
gender was not recorded. 
The study reported that a large proportion of those 
who started treatment completed it (83%, 58/70). 
Half (29/58) of those who completed treatment 
were drug free in the month prior to the interview. 
The abstinence rate for men (50%) was higher 
than that for women (39%). The proportion who 
committed at least one crime during the 30 days 
prior to interview was lower among those who had 
not used drugs in that time than among those who 
had, 15% compared to 30%. Five of the 29 who 
had used at least one drug in the last month had 
injected it. 
Although not directly comparable, these study 
fi ndings follow the same trend as those of the 
ROSIE study,2 which indicated that opiate treatment 
in residential facilities is reasonably successful. 
The limitations of this study are that there are no 
baseline data and drug-free status is self-reported. 
In addition, it is possible that other treatment 
interventions may have taken place between 
discharge from Keltoi and the study interview 
and these may account for some of the positive 
fi ndings. Nevertheless, these fi ndings indicate that 
the Keltoi approach to treatment for drug users can 
lead to favourable outcomes.
(Vivion McGuire and Jean Long)
1. Sweeney B, Browne C, McKiernan B and White 
E (2007) Keltoi client evaluation study. Dublin: 
Health Service Executive.
2. Cox G, Comiskey C and Kelly P (2007) ROSIE 
Findings 3: Summary of 1-year outcomes. 
Abstinence modality. Dublin: National Advisory 
Committee on Drugs.
On 25 January 2008, the National Advisory 
Committee on Drugs (NACD) and the Department 
of Health, Social Services and Public Safety 
(Northern Ireland) published jointly the second 
all-Ireland general population drug prevalence 
survey.1 Minister of State with responsibility for 
drugs strategy, Pat Carey TD, launched the fi ndings 
for Ireland. 
Drug prevalence surveys of the general population 
are important in that they can shed light on the 
patterns of drug use, both demographically and 
geographically and, when repeated, can track 
changes over time. They help to increase our 
understanding of drug use, and to formulate and 
evaluate drug policies. They also enable informed 
international comparisons provided countries 
conduct surveys in a comparable manner. 
The Irish survey followed best practice guidelines 
recommended by the European Monitoring Centre 
for Drugs and Drug Addiction (EMCDDA). The 
questionnaire, based on the ‘European Model 
Questionnaire’, was administered in face-to-face 
interviews with respondents aged between 15 and 
64 years normally resident in households in Ireland 
and Northern Ireland. With the exception of two 
questions and two show cards, the questionnaire 
employed for the 2006/7 survey was the same as 
that used in 2002/3.2 Fieldwork was carried out by 
MORI MRC during late 2006 and early 2007. The 
fi nal achieved sample was 4,967 in Ireland. This 
represented a response rate of 65%. The sample 
was weighted by gender, age and region to ensure 
that it was representative of the general population.
The proportion of adults (aged 15–64 years) who 
reported using an illegal drug in their lifetime 
increased by fi ve percentage points, from 19% in 
2002/3 to 24% in 2006/7 (Table 1). The proportion 
of young adults (aged 15–34 years) who reported 
using an illegal drug in their lifetime also increased 
by fi ve percentage points, from 26% in 2002/3 to 
31% in 2006/7. As expected, more men reported 
using an illegal drug in their lifetime than women. 
The proportion of adults who reported using an 
illegal drug in the last year increased marginally, 
from 6% in 2002/3 to 7% in 2006/7 (Table 1). The 
proportion of young adults who reported using an 
Keltoi completes an outcome study
Drug use in the general 
population, 2006/7: repeat survey
Dr Brion Sweeney, 
one of the authors of 
the Keltoi evaluation, 
speaking at the 
launch of the report 
(Photo: JJ Berkeley)
Mr Noel Mulvihill, 
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launch (Photo: JJ 
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drugnet 
IRELAND
16
illegal drug in the last year increased from 10% in 2002/3 
to 12% in 2006/7. The proportion of adults who reported 
using an illegal drug in the last month remained stable.
Cannabis was the most commonly used illegal drug in 
Ireland. The proportion of adults who reported using 
cannabis at some point in their life increased from 17% 
in 2002/3 to 22% in 2006/7 (Table 2). Proportions using 
cannabis refl ect the same pattern as the proportions using 
any illegal drug described above.
Nine per cent of young adults claimed to have tried ecstasy 
at least once in their lifetime in 2006/7 (Table 3). 
Cocaine use increased in 2006/7 compared to 2002/3. The 
proportion of adults who reported using cocaine (including 
crack) at some point in their lives increased from 3% in 
2002/3 to 5% in 2006/7 (Table 4). The proportion of 
young adults who reported using cocaine in their lifetime 
also increased, from 5% in 2002/3 to 8% in 2006/7. As 
expected, more men reported using cocaine in their lifetime 
than women.
The proportion of adults who reported using cocaine in 
the last year increased from 1% in 2002/3 to 2% in 2006/7 
(Table 4). The proportion of young adults who reported using 
cocaine in the last year increased from 2% in 2002/3 to 3% in 
2006/7. The proportion of adults who reported using cocaine 
in the last month remained stable at under 1%.
There was a considerable increase in the proportions using 
any illegal drug at some point in their lives. This is infl uenced 
by the fact that drug use in Ireland is a recent phenomenon 
and that the population of lifetime and recent drug users 
in Ireland is relatively young. Drug use is measured among 
adults aged 15–65, and those leaving this age group over 
the next fi fteen to twenty years are less likely to have been 
exposed to drug use than those entering the measurement 
cohort. 
Table 1   Lifetime, last-year and last-month prevalence of illegal drug use in Ireland, 2002/3 and 2006/7
Illegal 
drug use*
Adults
15–64 years %
Males
15–64 years %
Females
15–64 years %
Young adults
15–34 years %
2002/3 2006/7 2002/3 2006/7 2002/3 2006/7 2002/3 2006/7
Lifetime 18.5 24.0 24.0 29.4 13.1 18.5 26.0 31.4
Last year 5.6 7.2 7.8 9.6 3.4 4.7 9.7 12.1
Last month 3.0 2.9 4.1 4.3 1.7 1.4 5.2 4.8
* Illegal drugs in this context are amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, 
poppers and solvents.
Source: National Advisory Committee on Drugs and Drug and Alcohol Information and Research Unit (2005, 2008)
Table 2   Lifetime, last-year and last-month prevalence of cannabis use in Ireland, 2002/3 and 2006/7
Cannabis 
use
Adults
15–64 years %
Males
15–64 years %
Females
15–64 years %
Young adults
15–34 years %
2002/3 2006/7 2002/3 2006/7 2002/3 2006/7 2002/3 2006/7
Lifetime 17.4 21.9 22.4 27.0 12.3 16.6 24.0 28.6
Last year 5.0 6.3 7.2 8.5 2.9 3.9 8.6 10.4
Last month 2.6 2.6 3.4 4.0 1.7 1.1 4.3 4.2
Source: National Advisory Committee on Drugs and Drug and Alcohol Information and Research Unit (2005, 2008)
Table 3   Lifetime, last-year and last-month prevalence of ecstasy use in Ireland, 2002/2003
Ecstasy use Adults
15–64 years %
Males
15–64 years %
Females
15–64 years %
Young adults
15–34 years %
2002/3 2006/7 2002/3 2006/7 2002/3 2006/7 2002/3 2006/7
Lifetime 3.7 5.4 4.9 7.2 2.6 3.6 7.1 9.0
Last year 1.1 1.2 1.7 1.8 0.5 0.6 2.0 2.4
Last month 0.3 0.3 0.7 0.5 0.0 0.2 0.6 0.6
Source: National Advisory Committee on Drugs and Drug and Alcohol Information and Research Unit (2005, 2008)
Table 4   Lifetime, last-year and last-month prevalence of cocaine use (including crack) in Ireland, 2002/2003
Cocaine 
use
Adults
15–64 years %
Males
15–64 years %
Females
15–64 years %
Young adults
15–34 years %
2002/3 2006/7 2002/3 2006/7 2002/3 2006/7 2002/3 2006/7
Lifetime 3.0 5.3 4.3 7.0 1.6 3.5 4.7 8.2
Last year 1.1 1.7 1.7 2.3 0.5 1.0 2.0 3.1
Last month 0.3 0.5 0.7 0.8 0.0 0.2 0.7 1.0
Source: National Advisory Committee on Drugs and Drug and Alcohol Information and Research Unit (2005, 2008)
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Survey data on drug use in the last year shows an 
increase in the proportions using cannabis and, 
to a lesser extent, cocaine. These results follow 
trends observed in treatment data. At the launch 
of this report, Minister Carey said: ‘While cannabis 
continues to be the most commonly used illegal 
drug, cocaine use has grown, particularly among 
the young adult population. This fi nding is in line 
with [the fi ndings of a joint NACD/NDST] report 
on cocaine which was published last year, with the 
experiences of those working in the fi eld and with 
expectations generally.’ 
When compared to the 19 countries that completed 
a general population survey on drug use, Ireland 
ranks seventh for lifetime use of cannabis, fourth 
for lifetime use of amphetamines, fourth for use of 
cocaine, third for ecstasy and third for LSD.
(Jean Long)
1. National Advisory Committee on Drugs and 
Drug and Alcohol Information and Research Unit 
(2008) Drug use in Ireland and Northern Ireland: 
fi rst results from the 2006/2007 drug prevalence 
survey. Dublin: National Advisory Committee on 
Drugs.
2. National Advisory Committee on Drugs and 
Drug and Alcohol Information and Research 
Unit (2005) Drug use in Ireland and Northern 
Ireland: fi rst results (revised) from the 2002/2003 
drug prevalence survey. Dublin: National Advisory 
Committee on Drugs.
The annual report Activities of Irish psychiatric units 
and hospitals 2006, published by the Mental Health 
Research Unit of the Health Research Board in 
December 2007, shows that the total number of 
admissions to inpatient care has continued to fall.1 
In 2006, 2,767 cases were admitted to psychiatric 
facilities with an alcohol disorder, of whom 851 
were treated for the fi rst time.1 Figure 1 presents 
the rates of fi rst admission between 1990 and 2006 
of cases with a diagnosis of alcohol disorder, per 
100,000 of the population.1-5 It is notable that the 
rate decreased steadily between 1991 and 2004 
and more than halved during the reporting period. 
The rate stabilised in 2004 and 2005, but decreased 
again in 2006. The trend since the early nineties 
refl ects changes in alcohol treatment policy and 
practice, and the resultant increase in community-
based and special residential alcohol treatment 
services. Of the 2,733 discharges with an alcohol 
disorder, just under 41% spent less than one week 
in hospital and 19% spent more than one month 
in hospital. Whether or not these admissions were 
appropriate, and in line with the recommendations 
of the mental health policy, A vision for change, 
could not be discerned from the report as the 
numbers with co-morbid illness were not reported.
In 2006, 663 cases were admitted to psychiatric 
facilities with a drug disorder, of whom 250 
were treated for the fi rst time.1 The report does 
not present data on drug use and psychiatric co-
morbidity, so it is not possible to determine whether 
or not these admissions were appropriate. Figure 2 
presents the rates of fi rst admission between 1990 
and 2006 of cases with a diagnosis of drug disorder, 
per 100,000 of the population.1-5 The rate increased 
steadily between 1990 and 1995, with a dip in 
1996, and further annual increases between 1997 
and 2001. The rate was almost three times higher 
in 2001 than it was in 1990. Notable dips in the 
rate occur in the census years 1996 and 2002, and 
Trends in alcohol and drug 
admissions to psychiatric facilities
Figure 1 Rates of psychiatric fi rst admission of cases with a diagnosis of alcohol disorder (using 
the ICD-10 three character categories) per 100,000 of the population in Ireland and 
reported to the National Psychiatric Inpatient Reporting System, 1990 to 2006
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Problem cocaine use is now the third most common 
reason for presenting for drug treatment in Europe. 
In light of this, the European Monitoring Centre for 
Drugs and Drug Addiction (EMCDDA) has published 
a summary of research into the treatment of cocaine 
dependency from a European perspective.1 The main 
conclusions are highlighted here.
Psychosocial therapy is the mainstay of treatment 
for problem cocaine use but, despite lack of 
evidence, pharmacological treatment is also often 
used. However, there are some promising new 
pharmacological treatments such as topiramate (an 
anti-epileptic) and vaccination. 
Psychosocial treatments, such as contingency 
management, have shown promising results in 
American studies. Residential treatment has shown 
no greater benefi t than outpatient treatment. In 
general, the success rate of treatment for cocaine 
use is considered much lower than that for opioid 
dependence.
Polysubstance use is now a serious issue and 
appears to negatively affect treatment outcomes. 
Linked to this, there is evidence that crack cocaine 
users require different treatment to cocaine powder 
users. Therefore, specifi c treatment strategies, 
including harm reduction measures, need to be 
developed for these groups. Also highlighted was 
the need for intra-European studies to examine 
differences in crack cocaine use at local and 
national levels.
The majority of studies come from the US and, 
although these are useful, there is a need to 
conduct further research on treatments for cocaine 
users in a European context.
(Suzi Lyons)
1. EMCDDA (2007) Treatment of problem cocaine 
use: a review of the literature. Lisbon: European 
Monitoring Centre for Drugs and Drug 
Addiction.
EMCDDA review of literature on 
cocaine treatments
can be partly explained by the increased population 
fi gure used as the denominator in calculating the 
rate for those years. The overall increase in the rate 
of drug-related fi rst admissions between 1990 and 
2001 refl ects the increase in problem drug use in 
Ireland and its burden on the psychiatric services. 
The overall decrease in the rate since 2001 possibly 
refl ects an increase in community-based specialised 
addiction services during this period. The increased 
rate in 2005 may be accounted for by the use of 
the 2002 census fi gure in calculating the rate. The 
decrease to 5.9 in 2006 refl ects the new census 
fi gure used as denominator. Of the 659 discharges 
with a drug disorder, just under 48% spent less 
than one week in hospital and just over 17% spent 
more than one month in hospital.
(Jean Long)
1. Daly A, Walsh D and Moran R (2007) Activities 
of Irish psychiatric units and hospitals 2006. 
Dublin: Health Research Board.
2. Daly A, Walsh D, Ward M and Moran R (2006) 
Activities of Irish psychiatric units and hospitals 
2005. Dublin: Health Research Board.
3. Daly A, Walsh D, Comish J, Kartalova-O’Doherty 
Y, Moran R and O’Reilly A (2005) Activities of 
Irish psychiatric units and hospitals 2004. Dublin: 
Health Research Board.
4. Daly A, Walsh D, Moran R and Kartalova-
O’Doherty Y (2004) Activities of Irish psychiatric 
services 2003. Dublin: Health Research Board.
5. Walsh D and Daly A (2004) Mental illness in 
Ireland 1750–2002: refl ections on the rise and 
fall of institutional care. Dublin: Health Research 
Board.
Trends in psychiatric admissions (continued)
Figure 2 Rates of psychiatric fi rst admission of cases with a diagnosis of drug disorder (using 
the ICD-10 three character categories) per 100,000 of the population in Ireland and 
reported to the National Psychiatric Inpatient Reporting System, 1990 to 2006
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The European Legal Database on Drugs (ELDD) 
was launched by the European Monitoring Centre 
for Drugs and Drug Addiction in 2001, and is now 
recognised as the defi nitive source of information 
on European drug laws.1
The database holds four types of information:
Legal texts ■  containing over 800 texts, usually 
in the original language but often with English 
translations. 
Country profi les ■  outlining the legal aspects of the 
substances controlled and the main provisions 
of the various drug laws in all EU members 
states and Norway.
Topic overviews ■  of ’hot topics‘, such as the 
laws and penalties in relation to cannabis, 
drug classifi cation systems, and treatment 
alternatives to prosecution or prison. Recent 
additions include the legal status of drug testing 
at work, hallucinogenic mushrooms, needle and 
syringe programmes, driving after taking drugs, 
controlled deliveries and precursor traffi cking 
penalties.
Legal reports ■  providing more detailed, 
comparative analyses of the situation across 
Europe. For instance, the Substances and 
Classifi cations table lists 500 substances 
and their classifi cation under national and 
international legislation. Also included are 
reports on drug substitution treatment, 
decriminalisation, the legal aspects of medical 
cannabis, drugs and young people, and the 
role of the quantity in the prosecution of drug 
offences.
These resources are supplemented by a News 
service, which provides an email alert to registered 
users (general public) informing them of 
newsworthy changes to member states’ national 
laws or to EU laws or policies.2 Visitors to the site 
can avail of this service by completing a registration 
form online. A network of legal correspondents, 
appointed by the governments of the member 
states, provide the ELDD with updates on national 
legislation. The Irish legal correspondent is based in 
the Alcohol and Drug Research Unit of the HRB.
Forthcoming activities of the ELDD include 
completion of a study on the emergency 
scheduling of new drugs throughout the EU and 
Norway and of another study on existing EU-wide 
administrative or non-criminal punishments for 
drug offences.
A number of signifi cant legal provisions have 
been introduced into Irish law over the past two 
years.3 In October 2006, provisions of the Criminal 
Justice Act 2006 for the registration of convicted 
drug offenders with the Garda Síochána were 
introduced. These provisions apply specifi cally to 
individuals convicted of drug traffi cking offences 
and sentenced to a term of imprisonment of not 
less than one year. The Drug Offenders Register is 
based on the same principle as the Sex Offenders 
Register and will enable the movement of convicted 
drug dealers to be recorded in a similar manner; 
for instance, information relating to a change of 
address, or movement in or out of the country, 
must be supplied to the gardaí.
Parts 11 and 13 of the Criminal Justice Act 2006 
relating to anti-social behaviour orders (ASBOs) 
came into force on 1 January 2007 for adults 
and on 1 March for children (aged 12–18 years). 
ASBOs are measures introduced to tackle anti-
social behaviour such as intimidation, abusive or 
threatening behaviour and vandalism, some of 
which may be alcohol- and/or drug-related.
In May 2007, a number of new provisions 
contained in the Prisons Act 2007 came into force. 
Section 35 allows the Minister for Justice to make 
rules for the regulation and good government of 
prisons. Such rules may provide for the testing of 
prisoners for intoxicants, including alcohol and 
other drugs. Section 36 prohibits the unauthorised 
possession or use of a mobile phone by a prisoner, 
and the unauthorised supply of a mobile phone to 
a prisoner. There is anecdotal evidence that mobile 
phones have been instrumental in facilitating drug 
supply to prisons.
The Criminal Justice Act 2007 contains a number of 
important changes to the criminal justice system, 
including increased Garda detention powers, 
changes to existing provisions in relation to the 
right to silence, and the introduction of mandatory 
sentencing for a range of offences.4 Many of these 
changes have been introduced in the context of 
growing concern about drug-related crime.
(Johnny Connolly)
1. http://eldd.emcdda.europa.eu/
2. http://eldd.emcdda.europa.eu/?nnodeid=5176
3. For further details on these provisions, see 
Alcohol and Drug Research Unit (2007) 2007 
National Report (2006 data) to the EMCDDA 
by the Reitox National Focal Point. Ireland: new 
developments, trends and in-depth information on 
selected issues. Dublin: Health Research Board. 
An online copy can be found at http://www.
ndc.hrb.ie/
4. See Connolly J and Morgan A (2007) The 
Criminal Justice Act 2007. Drugnet Ireland, Issue 
22: 10.
European Legal Database on 
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The Horizontal Working Party on Drugs (HDG), 
a working group of the Council of the European 
Union, convened in December 2007 during the 
Portuguese presidency to discuss measures to curb 
the distribution of drugs at street level.1
Street-level drug markets and related crime 
and nuisance have been the focus of increased 
attention in recent years. Organisations such as 
the International Narcotics Control Board,2 the 
European Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA)3 and the Pompidou Group 
of the Council of Europe4 have highlighted the 
importance of this issue. In addressing the HDG, 
the EMCDDA points to the limitations of reliable 
data in this area. The EMCDDA is currently 
developing a project to improve local reporting of 
street-level drug distribution. 
Presentations from Portugal, the UK, Cyprus 
and Ireland gave an indication of the diversity of 
strategies employed by EU states to tackle open 
drug markets. However, a theme common to all 
presentations was the importance of effective 
partnerships between law enforcement, other 
statutory agencies and local communities. 
The Portuguese delegates emphasised the 
importance of partnership between policing 
authorities and local populations for the purpose 
of effective intelligence and information gathering. 
They identifi ed continuous monitoring of drug use 
and availability in local populations as a priority. 
In their presentation on a community policing 
project launched in 2003, the Cypriot delegation, 
also considered the importance of co-operation 
between law enforcement and the community. In 
that project, community police provide reassurance 
at local level by means of house-to-house calls, 
public lectures, visits to key areas and attendance at 
events within the community. 
A recent UK initiative involved a concentrated 
drive to disrupt drug markets, employing supply-
reduction methods within a multi-agency 
framework. The UK delegation reported that this 
initiative led to a decrease in acquisitive crime, a 
disruption of local drug markets and increased 
insight into how such markets operated. Focused 
legislation in place since 2003 has facilitated 
the rapid closure of over 1,000 premises used in 
connection with the sale and distribution of Class 
A drugs (‘crack houses’ in particular). Similarly to 
the other presenters, the UK delegates emphasised 
the importance of communication and partnership 
between the local population and law enforcement 
authorities. 
The Irish delegation provided an overview of 
recent local policing initiatives in the context of the 
establishment of pilot Joint Policing Committees 
(JPCs) under the provisions of the Garda Síochána 
Act 2005. These JPCs are to be established in 114 
local authority areas throughout the state. Their 
primary functions are to serve as a forum for 
consultation, discussion and recommendations on 
local policing matters and to keep under review 
levels of crime, disorder and anti-social behaviour, 
including the patterns and levels of misuse of 
alcohol and drugs. JPC members will be drawn 
from local authorities, gardaí, public representatives 
and representatives from the community and 
voluntary sector. Furthermore, Section 36 of 
the Garda Síochána Act, 2005 provides for the 
establishment of local policing fora by a JPC. In 
light of Action 11 of the National Drugs Strategy, 
priority will be given to establishing such fora in 
all local drugs task force areas and other areas 
experiencing problems of drug misuse. At present, 
the Department of Justice, Equality and Law reform 
is co-ordinating a process of drawing up guidelines 
for these local policing fora.
The HDG concluded that the sharing of information 
about best practice in this area was crucial 
in developing an EU-wide approach. It also 
highlighted the ongoing work of groups such as the 
Pompidou Group’s EXASS Net (European network 
of partnerships between stakeholders at frontline 
level responding to drug problems providing 
experience and assistance for inter-sectoral co-
operation),5 the European Forum for Urban Safety6 
and the European Crime Prevention Network.7
(Johnny Connolly and Anne Marie Donovan)
1. Horizontal Working Party on Drugs (2008) 
Conclusions on the thematic debate – preventing 
the distribution of drugs at street level. Cordrogue 
14 SAN 14. Brussels: Council of the European 
Union.
2. International Narcotics Control Board (INCB) 
(2004) Report 2003. New York: United Nations 
Publications.
3. EMCDDA (2005) Annual Report 2005: Selected 
issues. Luxembourg: Offi ce for Offi cial 
Publications of the European Communities.
4. Connolly J (2006) Responding to open drug 
scenes and drug-related crime and public nuisance 
– towards a partnership approach. Strasbourg: 
Pompidou Group, Council of Europe.
5. http://www.exass.net/forum/login.php
6. http://www.fesu.org/
7. http://www.eucpn.org/
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Report highlights limitations in Forensic 
Science Laboratory resources
A review of the Forensic Science Laboratory (FSL) by 
Professor Ingvar Kopp, former director of the Swedish 
National Forensic Science Laboratory and founding member 
of the European Network of Forensic Science Institutes, 
has found that approximately one-third of drug samples 
submitted by the Garda Síochána for analysis between 
2000 and 2006 were not processed because of resource 
limitations.1 As a consequence of this unmet demand 
for forensic services, he concludes, ‘the detection and 
prosecution of crime is weakened … particularly so in drug 
analysis cases, where a certifi cate is required for prosecution’ 
(p. 19).
Suspected drugs seized by the gardaí and by customs are 
submitted to the FSL for analysis to determine whether an 
illicit substance is present. Samples are submitted in tamper-
evident bags, with a Garda form which lists the items 
being submitted. The Kopp report points to unnecessary 
bureaucratic obstacles, stating that ‘in relation to drug 
cases, there is a lot of manual handling and duplication of 
data entry’ (p. 16). The process by which items are received 
is, according to the report, ‘very cumbersome’, due in 
part to legal constraints and in part ‘to practices grown 
with the development of the Laboratory’ (p. 16). A time-
consuming practice has developed whereby labels on the 
packing and detailed descriptions of the contents form part 
of the laboratory report. The report recommends that this 
practice be rationalised by means of FSL/Garda review of 
case management procedures and by the automation of 
procedures and minimisation of manual data entry. 
The report also notes, however, that legal constraints 
require rigorous procedures to be in place. It is not unusual, 
according to the report, ‘for the questioning in court to 
focus more on the physical appearance of the item rather 
than analytical results’ (p. 16). This can occur even in drug 
cases, as the court may want to probe ‘what the Garda 
recorded or saw prior to submitting the sample to the 
Laboratory’ (p. 16). Furthermore, beyond the focus on the 
appearance of evidence, ‘enormous and disproportionate 
demands’ are placed on the laboratory arising from the need 
to certify the chain of evidence. The report recommends that 
the Law Reform Commission or another suitable expert body 
be commissioned to conduct a study in order to ‘evaluate 
the scope for a more effi cient means of approaching the 
management of physical evidence’ (p. 17).
Table 1 shows the number of drug cases received by the FSL 
from the Garda Síochána and the number of cases reported 
(i.e. processed). Of the 61,639 drug cases submitted for 
analysis between 2000 and 2006, 41,230 were analysed, 
leaving a shortfall of 20,409, or just over 33%.
In addition to the unmet demands for the existing services 
available from the laboratory, the report points to the need 
for resources to cover an additional service, in the context of 
drug-related sexual assaults. The FSL has carried out alcohol 
determinations on biological samples submitted relating to 
victims of sexual assault. In more recent years, requests have 
been expanded to test for the presence of controlled drugs. 
However, the report points out that the FSL has not been 
able to meet this demand and estimates that, were it able 
to provide such a service, approximately 150 of such cases 
would arise annually. 
The report also emphasises the importance of the FSL 
engaging with academic and research institutions, and 
recommends that the Department of Justice, Equality 
and Law Reform fund and support the FSL so that it can 
participate in joint research projects with other institutions, 
such as the Health Research Board (p. 41). In relation to 
drug purity, for example, this approach could enhance 
our understanding of the operation of illicit drug markets. 
Systematic purity testing of drugs seized at all market levels 
can provide useful information on market dynamics and 
profi t margins.2 Forensic analysis of seized drugs can also 
provide us with information on the types of dilutants used 
to bulk up drugs for street sale, a practice which can have 
important health consequences for drug users. 
Although the FSL sometimes conducts ad hoc studies, only a 
very small proportion of drugs seized are tested to ascertain 
their percentage purity. For example, in 2003, the laboratory 
received over 600 suspected heroin cases, of which 11 were 
analysed to determine their percentage purity.2 Further 
research such as that recommended in this report would 
assist in providing an evidence-base upon which to develop 
criminal justice interventions.
The study concluded that the current resource limitations 
have implications for crime control and law enforcement:
The consequences of the current inability to 
meet actual and suppressed demands are serious. 
Investigations and prosecutions which could benefi t 
from forensic analysis are deprived of additional 
insight and this has inevitable consequences in the 
fi ght against crime. (p. 8)
(Johnny Connolly)
1. Kopp I (2007) Review of resource needs in the Forensic 
Science Laboratory and the wider scientifi c context in 
Ireland. Dublin: Department of Health and Children.
2. Connolly J (2005) The illicit drug market in Ireland. 
Overview 2. Dublin: Health Research Board.
Table 1   Number of drug cases received and reported by the Forensic Science Laboratory 2000–2006 
2000 2001 2002 2003 2004 2005 2006 Total
Cases received 8658 10715 8673 8470 8192 8079 8852 61639
Cases reported 5111 5813 4764 5653 6251 6390 7248 41230
Shortfall 3547 4902 3909 2817 1941 1689 1604 20409
Source: Kopp (2007)
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Addressing crime and anti-social 
behaviour in Limerick
The Fitzgerald Report recently submitted to the 
Cabinet Committee on Social Inclusion addresses 
social exclusion, crime and disorder issues in the 
Moyross and Southill communities and other 
disadvantaged areas in Limerick city.1 The report 
advocates a strategic response which includes: 
interventions to address the issue of serious  ■
criminality; 
economic and infrastructural regeneration;  ■
Co-ordination between local authorities, gardaí  ■
and community and voluntary sector agencies 
to tackle entrenched disadvantage.
The report provides evidence from a variety of 
sources which highlights the decreasing quality of 
life in these communities. In particular, it points to 
statistics compiled by the Central Statistics Offi ce 
indicating that these areas ‘are among the most 
deprived in the country’ (p. 5). Additional evidence 
collected by the author and his team indicates 
that members of these communities have suffered 
violent intimidation and damage to personal and 
council property from so-called ‘criminal elements’. 
Other concerns include the number of young 
people involved in anti-social behaviour and drug 
distribution.
The report emphasises that economic and social 
regeneration cannot happen without ‘intensive 
policing arrangements’ (p. 8). It states that 
‘dealing with the serious (although relatively 
small in number) criminal elements … will be 
fundamental to creating the conditions for real 
progress to be achieved on all other fronts’ (p. 6). 
This policing initiative will occur in the context of 
a fi ve-year programme, the objective of which is to 
‘normalise and stabilise these areas’ (p. 8). Specifi c 
recommendations include:
targeting the assets of criminals by establishing  ■
a local CAB operation; 
maintaining a highly visible Garda presence in  ■
the area, which would involve dedicating up 
to 100 gardaí to these communities to restore 
public order and deal with criminal activity;
empowering Limerick City Council to evict  ■
tenants involved in criminal or anti-social 
behaviour.
It is proposed that two new geographically defi ned 
development agencies (Limerick Southside and 
Limerick Northside) be established to co-ordinate 
the delivery of economic and social regeneration. 
With these structures in place, the report 
recommends a number of economic and social 
initiatives to address disadvantage, including:
the attraction of commercial investment into  ■
these communities via fi scal incentive schemes; 
the development of transport infrastructure and  ■
access to these communities;
the total regeneration of housing stock in these  ■
estates, including a mix of social and private 
housing. 
It is recommended that special teams be 
established to co-ordinate the efforts of existing 
bodies to provide intensive and targeted 
interventions to local residents and families. These 
teams will be multi-disciplinary and are to include 
educational welfare offi cers, family support workers, 
local drugs taskforce and HSE representatives and 
community gardaí. Particular emphasis is to be 
place on the provision of activities and amenities 
for young people in the evenings and summer 
holidays.
In terms of drug abuse, Limerick city currently 
falls within the remit of the Mid-Western Regional 
Drugs Task Force. However, the report recommends 
that Limerick city benefi t from local intervention 
initiatives, given that ‘the problems of drug abuse 
in Limerick city are particularly acute’ (p. 12). These 
interventions should also include prevention and 
education initiatives.
(Anne Marie Donovan and Johnny Connolly)
1. Fitzgerald J (2007) Addressing issues of social 
exclusion in Moyross and other disadvantaged areas 
of Limerick City: report to the Cabinet Committee 
on Social Inclusion. Dublin: Department of 
Community, Rural and Gaeltacht Affairs.
Have your contact details changed?
We want to make sure that our mailing lists contain the correct contact details for all our readers.  
If there have been any changes to your title, organisation, address (postal or email), or telephone 
number, please let us know so that we can update our records. 
You can contact the Alcohol and Drug Research Unit by telephone at (01) 2345 127, 
or by email at adru@hrb.ie.
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The Central Statistics Offi ce (CSO) is responsible for 
classifying the cause of all deaths in Ireland. In 1968 a 
statistical return (Form 104) was introduced ‘to supplement 
the information on the Coroner’s Certifi cate for the better 
statistical classifi cation of cause of death’. The form was 
expanded in 1998 to facilitate a more detailed recording of 
the circumstances surrounding unexpected deaths, and now 
contains a number of mandatory fi elds: socio-demographic 
information, medical history, psychosocial factors, 
circumstances of death and contributing factors. 
Deaths that lead to a coroner’s inquest generally involve a 
chain of notifi cations and information transfers. The Garda 
Síochána are bound to report to the coroner any death 
that is unexpected, the result of an accident or suicide, or 
occurs in suspicious circumstances. Following an inquest, 
the coroner’s certifi cate recording the verdict is forwarded to 
the Registrar of Births, Deaths and Marriages. The Registrar 
records the death on a death registration form (Form 102) 
and sends this form and the coroner’s certifi cate to the CSO. 
The CSO uses this information to partially complete Form 
104, which is then sent to the notifying Garda. The Garda 
completes the form, including a statement of his/her opinion 
as to whether the death was accidental, suicidal, homicidal 
or undetermined, and returns it to the CSO. Staff at the CSO 
determine the classifi cation of the cause of death using the 
coroner’s certifi cate, the death registration form (Form 102) 
and the statistical return (Form 104).
A report by the National Suicide Research Foundation 
presents the results of a study analysing data routinely 
collected in 2002 by means of Form 104.1 A specifi c 
objective was to evaluate the usefulness of this form for 
collecting routine data on deaths, particularly suicides, that 
led to an inquest.
In 2002, 1,815 deaths required an inquest, of which 6% 
were not registered on time and were not included in the 
offi cial statistics for that year, resulting in an underestimation 
of the number and causes of death. Almost half (48%) of the 
inquests took place within six months of death. Fifteen per 
cent were performed more than a year after death, of which 
9%–15% were in provinces outside Dublin, and 27% were 
within Dublin. Over a quarter (26.5%) of inquests in which 
the cause of death was undetermined took place more than 
12 months after death, compared to 8% of inquests that 
resulted in a verdict of suicide. 
A Form 104 was completed for 1,718 (95%) of all the deaths 
in 2002 that led to an inquest. These forms had a high 
level of completeness for socio-demographic information 
(75% and above) but low levels for medical history and 
contributing factors (35% and below). In 88% of cases, 
Garda opinion as to the cause of death (as recorded on Form 
104) agreed with that of the CSO. 
The majority of unreturned forms related to deaths registered 
in Dublin. This may have led to inaccurate recording of 
the external causes of deaths in the area. Furthermore, 
the authors suggest that cases of suicide in Dublin were 
commonly misclassifi ed as being of ‘undetermined intent’, 
which may partially explain the lower suicide rate found in 
Dublin compared to other areas of the country. 
The most important fi ndings were: 
The highest suicide rates occurred on Mondays, and in  ■
the months of April, May and June.
The suicide rate for men (20.5 per 100,000) was higher  ■
then that for women (5.1).2
The suicide rate for unemployed men (88.8 per 100,000)  ■
was higher than that for employed men (23.9).
In general, a higher proportion of male deaths than  ■
female deaths were alcohol dependent.
Fifteen per cent of suicide deaths were alcohol  ■
dependent, compared to one-fi fth of deaths by accident, 
homicide or undetermined cause.
One-third of undetermined deaths were drug  ■
dependent, compared to 13% of accidental deaths.
Of the homicide deaths, one-quarter of the men were  ■
drug dependent, compared to none of the women. 
Of the suicide deaths, 34% of women were drug  ■
dependent, compared to 16% of men, and a higher 
percentage of women than men were dependent on 
prescription medication.
Although Form 104 has increased the range of information 
that can be collected at the time of death, it has some 
limitations, notably in that it does not have a ‘natural death’ 
option. This has resulted in submission by Garda members 
of incomplete forms or separate additional handwritten 
explanations. During the study period, all records were 
paper-based and liable to contain transcribing errors, which 
added to the inconsistencies in the data collected. However, 
the information is now recorded electronically, which the 
authors state should lead to a decrease in data-entry errors. 
The authors make a number of recommendations:
A new system should be developed to record medical  ■
and psycho-social information on deaths that lead to an 
inquest.
Form 104 should be improved where possible but  ■
remain in use until a suitable alternative is developed. 
A clear written protocol should be provided to the gardaí  ■
nationally, to standardise information recorded on Form 
104, especially for classifi cation of suicides.
Unnecessary delays in holding inquests should be  ■
identifi ed and improvements made where necessary to 
reduce distress for the bereaved family and improve the 
timeliness of routine mortality statistics.
(Suzi Lyons and Simone Walsh)
1. National Suicide Research Foundation (2007) Inquested 
deaths in Ireland: a study of routine data and recording 
procedures. Cork: National Suicide Research Foundation.
2. Based on population data from the 2002 National 
Census.
Data collection and recording of deaths 
that lead to a coroner’s inquest
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The fi rst meeting of the EU Civil Society Forum on Drugs 
was held in Brussels on 13 and 14 December 2007. Two Irish 
groups were among the 26 networks from EU member states 
selected to participate in the Forum – the Drug Policy Action 
Group and CityWide Drugs Crisis Campaign. Participation 
is for a two-year period, at the end of which there will once 
again be an open call for participants.
The establishment of this Forum is an important 
development in that it demonstrates the EU’s willingness to 
accept that drug issues warrant discussion and that much 
of the expertise lies in the community. However, the EU 
recognises its limited powers in these matters, except in the 
areas of border control and policing, which raises questions 
about how much real impact the EU Drugs Strategy can 
have within individual member states.
The meeting had three main themes: (1) the Drugs 
Prevention and Information Programme; (2) drugs and 
prisons; (3) the EU Action Plan on Drugs. Participants initially 
met as a plenary group but then broke into two parallel 
working groups to discuss themes 2 and 3.
The Drugs Prevention and Information Programme (2007–2012)
This programme was presented to participants as a potential 
funding opportunity. As part of the programme, there will 
be a call in early 2008 for proposals for grant funding from 
organisations in all EU member states under various themes, 
including the creation of multidisciplinary networks, drug 
prevention and harm reduction, civil society involvement, 
and monitoring and evaluation of specifi c actions under the 
Action Plans 2005–2008 and 2008–2012.1
Drugs and prisons
EU work to date in relation to this matter was presented to 
participants. An external contractor was employed in 2006 
to report on prevention, treatment and harm reduction 
services for people in prison, reintegration services upon 
release, and current approaches to monitoring and analysis 
of drug use among prisoners. This report was due to be 
fi nalised towards the end of 2007.
The Working Group on Drugs and Prisons was asked to ‘discuss 
and report on common views for the preparation of the future 
proposal for a Council recommendation on drugs and prison’, 
bearing in mind the presentation they had just heard and their 
own experiences. The issues raised included: equivalency of 
care issues, access to and the structure of treatment in prison, 
discharge plans and civil/human rights violations of prisoners in 
general, but especially of drug-using prisoners.
EU Action Plan on Drugs 
The objective of the Working Group on the EU Action Plan 
on Drugs was to provide insights from civil society relevant 
to the evaluation of the Action Plan on Drugs 2005–2008 
and, crucially, to the development of the Action Plan on 
Drugs 2009–2012. Issues raised included: polydrug use and 
the need for a wide range of treatment interventions, the 
needs of mobile drug users and of under-18s, and the need 
for a glossary of terms and defi nitions to accompany EU 
documents on drug issues.
The Action Plan 2009–2012 will be developed within the 
framework of the EU Drugs Strategy 2005–2012. Members 
of civil society can contribute to this process by sending 
written submissions on these points to the Commission.2 It 
was emphasised that submissions should be ‘realistic’ and ‘to 
the point’ and that the Commission would decide ‘how’ and 
‘when’ contributions would be used. 
Refl ections
Some aspects of the organisation of the Forum ran  ■
contrary to the spirit of civil society engagement: 
Details about the location and timing of the event • 
were sent to members very late in the process. 
This meant that a number of networks, including 
DrugScope UK and the International Harm Reduction 
Association (IHRA), were unable to attend. This 
limited the scope and the quality of debate and 
feedback.
Documentation (including the agenda) was not • 
received in advance of the event, so that participants 
were unaware of what issues to prepare for and were 
unable to consult with their membership.
Participants were presented with a large folder of • 
documents upon arrival and had little time to read 
them and respond comprehensively and, again, had 
no opportunity to consult members. 
The Commission exerts very strong control in relation to  ■
the use of contributions and submissions.
Participants were asked to leave ideologies ‘outside the  ■
room’. This proved very diffi cult for some participants 
and made some discussions diffi cult. 
Next steps
In the light of the problems outlined above and the fact that 
the new Action Plan will be developed during March/April 
2008, it was suggested that the Forum meet again in Spring, 
allowing participants time to consult with their members 
and provide valuable feedback and recommendations.
The Commission did acknowledge and apologise for the 
manner in which the event was organised and the delay 
in sending documentation, promising to do better in the 
future. They agreed to send a full list of Forum participants 
and a summary report to all who attended; they also agreed 
to explore the possibility of having a meeting in Spring 
2008. As yet, there has been no feedback on these matters.
However, despite the diffi culties outlined, there is still value 
in engaging in this process for the following reasons:
It provides an opportunity to infl uence the new Action  ■
Plan on Drugs 2009–2012.
Although the EU Drugs Strategy and Action Plans  ■
have no legal basis, recommendations made in such 
documents can be used as leverage in negotiations and 
can guide best practice.
It is an opportunity to network, to learn and to infl uence  ■
other Forum members and the Commission, specifi cally 
the Anti-drugs Policy Co-ordination Unit.
(Niamh Randall, with thanks to Anna Quigley from CityWide)
Niamh Randall is Policy and Communications Offi cer with 
Merchants Quay Ireland and co-ordinator of the Drug Policy 
Action Group (www.drugpolicy.ie)
1. Application forms and guidance notes are available on 
the website: http://ec.europa.eu/justice_home/funding 
2. For further information email JLS-DRUGS-PROGRAMME@
ec.europa.eu
EU Civil Society Forum on Drugs
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The Health Protection Surveillance Centre (HPSC) 
annual report was published in December 2007.1 
The centre collates data on cases of infectious 
diseases, including those that are notifi able. Three 
infections are of particular importance in injecting 
drug users – HIV, hepatitis B and hepatitis C. The 
number of HIV cases and their characteristics were 
reported in a previous issue of Drugnet Ireland.2 
Hepatitis C became a notifi able disease in 2004. In 
recent years, hepatitis C was primarily transmitted in 
Ireland through sharing equipment used to prepare 
and inject illicit drugs. The numbers of cases notifi ed 
each year between 2004 and 2006 are reasonably 
high (Table 1). Seventy-fi ve per cent of cases were 
reported by HSE services in Dublin, Kildare and 
Wicklow. Sixty-four per cent of cases were male and 
71% were aged between 25 and 44 years. Risk factor 
data were not available for the cases recorded in 
these years, but the profi le of cases corresponds with 
that of injecting drug users. The HPSC will collect risk 
factor data from 2007 onwards.
Hepatitis B is a vaccine-preventable disease which 
is transmitted through contact with blood or body 
fl uids of an infected person. The main routes of 
transmission are mother-to-baby, child-to-child, 
sexual contact and unsafe injections. The number 
of cases notifi ed to the HPSC increased each year 
between 1996 and 2005, and decreased by 8% in 
2006. There were 820 cases in 2006, of whom 668 
had a chronic infection, 93 had an acute infection 
and the disease status of 59 cases was unknown. 
Risk factor data have been reported since 2004 but 
the number of cases for which they are reported is 
very low. There is little specifi c data about hepatitis 
B among injecting drug users.
(Jean Long)
1. Health Protection Surveillance Centre (2007) 
Annual Report 2006. Dublin: Health Service 
Executive. 
2. Long J (Autumn 2007) New data on the 
incidence of HIV. Drugnet Ireland. Issue 23: 15.
The Wheel is a support and representative body 
connecting community and voluntary organisations 
across Ireland. In 2004, the organisation initiated 
research into the training needs of this sector. This 
culminated in the development of a three-tiered 
pilot programme, called Sector Skills, designed to 
address priority training needs:
Training Links ■  – a training networking 
programme designed to provide an 
organisation-led approach to training and 
development in the non-profi t sector, and 
to promote and support the development of 
training networks. 
Stronger Leaders ■  – a leadership development 
programme, tailored for leaders of non-profi t, 
community and voluntary organisations.
Learningpoint.ie ■  – a training opportunities 
website providing a single source of accurate, 
up-to-date information about training 
opportunities throughout the community and 
voluntary sector in Ireland.
The pilot phase for the Sector Skills initiative, which 
was part-funded by the Department of Enterprise, 
Trade and Employment,1 ran from August 2005 to 
July 2007. An evaluation report of this phase was 
launched by Minister Billy Kelleher in December 
2007.2
Deirdre Garvey, CEO of The Wheel, congratulated 
everyone who took part in the programme. 
She also welcomed the positive feedback from 
the evaluators; who examined all aspects of the 
programme, identifi ed strengths and weaknesses, 
and made recommendations for the future.
(Mary Dunne)
1. The National Training Fund provided 80% of 
the costs and The Wheel sourced the remaining 
20%. The Department of Community, Rural and 
Gaeltacht Affairs funded 10% of the costs of the 
www.learningpoint.ie website.
2. Coughlan C and Corrigan Matthews B (2007) 
Sector skills programme: fi nal evaluation report. 
Dublin: The Wheel. www.wheel.ie/user/sector_
skills/sector_skills_evaluation_report
Sector skills: training for the non-
profi t sector
Health Protection Surveillance 
Centre annual report 2006
Table 1   Numbers of hepatitis C cases notifi ed to 
the Health Protection Surveillance Centre, 2004 
to 2006
Year Number of cases notifi ed
2004 1131
2005 1434
2006 1226
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Under its customer charter, the State Laboratory is 
committed to providing a top quality analytical and advisory 
service for all its customers in an effi cient and effective 
manner.
The Human Toxicology Section of the Laboratory provides 
analytical support for criminal investigations and for 
coroners’ investigations. The State Laboratory provides 
analysis on post-mortem biological samples to identify the 
presence or absence of legal drugs, illegal drugs and other 
substances and to quantify the levels of these substances. 
Information provided can indicate whether the deceased was 
taking medication or was under the infl uence of alcohol or 
drugs at the time of death, or whether a drug overdose was 
involved.
The main analyses carried out by the Human Toxicology 
Section in 2006 were ethanol determination, drug screening, 
drugs of abuse screening, quantifi cation and determination 
of prescribed drugs and carbon monoxide determination. 
The screening for prescribed drugs can identify over 250 
different drugs. Specifi c analyses are also available for illegal 
drugs, such as cocaine, ecstasy, opiates and cannabinoids. 
These drugs can be quantifi ed and confi rmed to a level that 
will satisfy the scrutiny of a court of law. 
A total of 2,813 samples were analysed during 2006, an 
increase of 21.7% on the fi gure for 2000. Of these samples, 
2,743 (97.5%) were analysed for coroners’ cases and 70 
(2.5%) were for analysed for criminal cases. Confi rmatory 
analyses carried out included 1,318 opiate analyses, 411 
amphetamine (including ecstasy) analyses, 481 cocaine 
analyses and 360 cannabinoid analyses. The most commonly 
found prescribed drugs were diazepam and metabolite (658 
results), methadone (160 results) and paracetamol (146 
results).
(Lorraine Coleman)
The State Laboratory website is at www.statelab.ie
1. The State Laboratory (2007) Annual Report 2006. Dublin: 
The State Laboratory.
The State Laboratory annual report 2006
On Friday 1 February, the Family Support Network held 
its ninth annual Service of Commemoration and Hope, 
entitled ’New Beginnings‘, in remembrance of those who 
have died from drug use and related causes. The service in 
Our Lady of Lourdes Church, Sean McDermott Street, was 
attended by Minister Pat Carey TD, a representative of the 
Taoiseach, the Lord Mayor of Dublin, Bishop Eamon Walsh 
and other religious representatives, as well family members, 
friends and representatives from family support groups 
throughout the island of Ireland and many people working in 
this area. The Minister, Bishop Walsh and Fr Edmond Grace 
spoke to the packed church, and prayers and poems were 
read, accompanied by music provided by the Dublin West 
Community Church Music Group.
The Family Support Network was announced as an 
independent organisation in November 2007. Formed 
in 2000 under the auspices of the CityWide Drugs Crisis 
Campaign, the Network consists of representatives of 
family support groups, individual family members and 
those working directly with families of drug users. It aims 
to raise awareness of family support work and its role in the 
community; highlight the importance and value of work 
done by family support groups; provide information to 
families and communities on existing services and supports; 
highlight the extent of the drugs problem and its effects 
on families; campaign for better services for drug users and 
their families; support the involvement of the people most 
affected – drug users and their families – in dealing with the 
problem; and remember and commemorate those who have 
died as a result of drugs.
(Suzi Lyons)
Contact the Family Support Network at 175 North Strand 
Road, Dublin 1. Tel: 01 8365168 or email: sadietgrace@
gmail.com
Ninth annual Service of Commemoration 
and Hope
Most Reverend Eamonn Walsh DD speaking at the 
service (Photo: JJ Berkeley)
Members of the congregation (Photo: JJ Berkeley)
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The National Documentation Centre on Drug Use has 
published a new edition of the Directory of courses 
and training programmes on drug misuse in Ireland. 
Thirty-six providers sent us information about 94 
courses for this third edition. We would like to thank all 
of those who made contributions.
The Directory lists a range of training available, from 
single sessions to courses lasting up to two years. A wide 
variety of training standards, methods and approaches 
are represented. We do not assess the quality of courses 
listed; we present information as supplied by the 
course co-ordinators on course length, assessment, 
qualifi cations and accreditation.
Most courses are targeted at a specifi c audience. In 
particular, a large number of courses and training 
programmes have been designed for workers in the 
area of drug misuse and for parents. Many are offered 
at both in-house and external locations. Some courses 
do not refer directly to drugs or addiction but aim to 
develop broad skills, such as supervision, facilitation 
and counselling techniques, which may be of interest 
to those working in this area. 
Course providers are based in Dublin (61%), Cavan, 
Donegal, Kildare, Mayo, Meath, Tipperary, Waterford 
and Wexford. Although many cater specifi cally for 
people in their locality, some also offer courses on a 
regional or national basis.
(Mary Dunne)
Course co-ordinators who wish to revise an existing 
entry or include a new course in the 2009 edition of 
the Directory may request an application form from 
mdunne@hrb.ie
Directory of training courses for 
2008
Landsdowne Market Research recently carried out 
a survey on behalf of Eireann Healthcare on public 
attitudes towards and knowledge about over-the-
counter (OTC) medicines.1 Five questions on the 
subject were put to a sample of 908 people:
Which, if any, of these complaints do you 1. 
think aspirin helps: headache; toothache; 
stomach pain; heart disease; or other?
What is the youngest age at which it is 2. 
advisable to give a child aspirin?
Should paracetamol tablets be taken during 3. 
pregnancy?
Which of the following can only be treated 4. 
by prescription medicine: eczema; ulcers; 
stomach complaints; period pain; thrush; 
migraine or diarrhoea?
If the medicine you needed for a minor illness 5. 
was available without visiting a GP, would 
you be confi dent to take that option?
Results were categorised according to age, 
gender, marital status, social class and region. 
Key fi ndings from the survey showed that:
More than one in four people (26%) think  ■
aspirin helps stomach pain. Aspirin may in 
fact be potentially dangerous for people 
with stomach pain as it may be a symptom 
of ulcers, and aspirin can cause ulcers to 
perforate.
Less than one-third of people surveyed  ■
know that OTC medication is available for 
thrush and would visit a GP for prescription 
medication rather than self-medicate.
Almost half of respondents (45%) were  ■
unaware that OTC medication was available 
for eczema and would visit a GP for 
prescription medication.
Almost half of respondents (48%) would give  ■
aspirin to children under 16.
Only 34% of female respondents knew about  ■
the dangers of taking paracetamol during 
pregnancy.
Eighty fi ve per cent of people surveyed would  ■
be confi dent to receive OTC treatment for a 
minor illness from a pharmacist rather than a 
GP if the option was available.
(Lorraine Coleman)
1. Nalini Nathan of First Medical 
Communications provided an outline of 
the survey results for this article. www.
fi rstmedical.ie
Over-the-counter medicines – 
survey results
Father Joe Lucey  RIP
The late Father Joe Lucey SDB spent over 15 years working and living in the community of Dublin’s North 
East inner city. Based at the Crinan Youth Project in Seán McDermott Street, Fr Lucey worked with several 
organisations and was instrumental in the development of initiatives to benefi t the local community.
He will be sadly missed by all who knew him.
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Standardising the monitoring of drug-related 
public expenditure
Article by Luis Prieto, Drugnet Europe No. 61, 
January–March 2008, p. 3.
Producing estimates of drug-related public 
expenditure is one of the many targets set by 
the current EU drugs action plan (2005–2008). 
In this light, the EMCDDA is working to identify 
and test suitable monitoring tools with the aim 
of developing a common EU methodology for 
data-collection in this area. The ultimate goal is 
to quantify how much countries are spending on 
addressing the drug problem (e.g. healthcare, law 
enforcement, social services, drug policies). This will 
in turn provide policy-makers with the evidence-
base they need when allocating resources to drug-
related programmes and services.
The EMCDDA’s strategy for developing such a 
common methodology received the support of 
an expert meeting held in Lisbon from 13–14 
December, attended by 14 consultants from 
the areas of drug policy and economics. This 
methodology is based on a classifi cation of 
expenditure divided into two types: ‘labelled’ and 
‘unlabelled’.
‘Labelled expenditure’ refers to planned spending, 
refl ecting the voluntary commitment of the state in 
the drugs fi eld, and can be traced by exhaustively 
reviewing offi cial accountancy documents over 
a given period. However, estimates are often 
complicated when expenditure is embedded 
in programmes with broader goals (e.g. overall 
police operations budget). In such cases, 
‘unlabelled expenditure’ is estimated through 
modelling techniques. It is hoped that this new, 
twofold approach will not only provide more 
comprehensive and accurate estimates of public 
spending in tackling drugs and drug addiction 
Europe-wide but also strengthen governments’ 
commitment to budgetary transparency and 
accountability.
From Drugnet Europe
While the Irish government is ultimately responsible 
for drug policy in Ireland, the content of that policy 
evolves through a complex process of research, 
analysis and ongoing debate. The National 
Documentation Centre (NDC) has collected the 
current suite of Irish drug-related policy documents, 
together with a record of Irish Parliamentary debates 
on the drugs issue and links to the wider network 
of international, national, regional and local bodies 
that contribute to thinking and debate on the issue 
in Ireland. This material is now available on a new 
Drugs Policy page on the NDC website.
This web page provides a framework for accessing 
the websites of the main bodies engaged in 
infl uencing the formulation of Ireland’s policy on 
illicit drugs, be it through drug-related research, 
information exchange, debate on the issues, or 
policy development. 
The bodies contributing to or infl uencing the 
formulation of Ireland’s illicit drugs policy fall into 
six broad categories. Information on the most 
infl uential bodies in each category, and links to key 
policy documents produced by or associated with 
them, are available under each of these headings:
European Union institutions and agencies
International and European non-governmental 
organisations 
Irish drugs policy and co-ordination 
Irish non-governmental organisations 
Other inter-governmental bodies 
United Nations institutions and agencies 
The Drugs Policy page can be accessed through the 
Drugs in Ireland page on the NDC website at www.
hrb.ie/ndc.
New Drugs Policy page on NDC 
website
Drugnet Europe is the quarterly 
newsletter of the European 
Monitoring Centre for Drugs and 
Drug Addiction (EMCDDA) and is 
available at www.emcdda.europa.eu.
If you would like a hard copy of 
the current or future issues, please 
contact: 
Alcohol and Drug Research Unit
Health Research Board 
Knockmaun House 
42-47 Lower Mount Street 
Dublin 2 
Tel: 01 2345 127; Email: adru@hrb.ie
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On 1 November 2007 the Policing Priorities for An Garda 
Síochána for 2008 were announced by Brian Lenihan TD, 
Minister for Justice, Equality and Law Reform. A top priority, 
which the Garda Commissioner must take into account in 
preparing his policing plan for 2008, is gun crime, organised 
crime and drugs. The aims are: 
targeting through the use, in particular, of specialist units  ■
and targeted operations such as Operation Anvil; 
profi ling, intelligence gathering and threat assessments in  ■
relation to individuals/ groups involved in these categories 
of crime; 
delivery on Garda actions and performances set out in the  ■
National Drugs Strategy; 
the pursuit by the Criminal Assets Bureau (CAB) of the  ■
proceeds of crime, including, through the presence of 
enhanced liaison arrangements between Garda divisions 
and CAB, the assets of those engaged at any level in drug 
dealing; and 
enhanced activities by the Drugs Units and the Force  ■
focusing, in particular, on places throughout the country 
where the presence of drug dealing and the use of illicit 
drugs is likely. www.garda.ie
On 15 November 2007 the Social Inclusion Report Ireland 
2006–2007 was launched. It reports on progress against the 
targets/actions contained in NAPinclusion 2007–2016, i.e. 
the National Action Plan for Social Inclusion. It lists the targets 
and progress for drug-related measures under Children and 
Communities. www.socialinclusion.ie 
In November 2007 the Irish Prison Chaplains Annual Report 
2006/07 was submitted to the Minister for Justice. Overall, 
it argues for a shift from punitive to restorative justice. In 
respect of drugs, the report states: ‘The misuse of drugs 
continues to be a major problem in most of our prisons. We 
welcome the introduction of drug counsellors and addiction 
nurses and we hope that their expertise in dealing with drug 
addiction will help address the drug culture that prevails. 
Given the ongoing debate around methadone maintenance, 
we hope this additional service will offer greater possibilities 
and opportunities to those struggling to remain drug free. 
We strongly recommend that resources be made available 
for those prisoners who plead for help in the whole area of 
drug addiction. To date, at any given time only nine prisoners 
may avail of a special six-week course in Mountjoy to address 
their addiction. Surely this must be seen to be insuffi cient 
when the drug addiction is the cause of so many prisoners 
been incarcerated in the fi rst place. There are numerous 
prisoners who look for a drug free landing in order to stay 
away from drugs but they are few in number. Many people 
will in fact have been introduced to drugs initially while they 
were in prison. Sniffer dogs have been introduced in some 
prisons, which have reduced the quantity of drugs getting 
into the prison. This can cause tension on the landings 
when the supply is short. We call for a systematic approach 
to be implemented so that as the supply is diminished the 
appropriate support be offered in its place.’ www.cfj.ie 
On 5 December 2007 the Drugs Initiative budget for 2008 
was announced. The following day, Minister of State Pat Carey 
TD stated in Dáil Éireann: ‘In respect of the area for which 
I am responsible, I welcome the €12.5 million increase in 
funding for drugs programmes in 2008, which the Minister 
for Finance announced in yesterday’s budget. This increase of 
more than 25% constitutes a major funding boost for drugs 
programmes next year and builds on increases in funding 
secured for these programmes in the past three years. It 
reaffi rms the high priority the Government continues to give 
to tackling the drugs problem. The 2008 allocation of €64 
million, of which almost €56 million is current funding and 
€8 million is capital funding, will facilitate progress towards 
the fulfi lment of drug-related commitments in the programme 
for Government.’ www.oireachtas.ie 
On 20 December 2007 the Irish Prison Service published 
its annual report for 2006. The document reports overall 
progress in relation to drug treatment and rehabilitation 
services and the elimination of the supply of drugs in prisons. 
It also includes reports in respect of each individual prison: 
statistics are given on methadone treatment in prisons, and 
the number of those in prison on drug offences, including a 
breakdown by age of offender and length of sentence. www.
irishprisons.ie 
In December 2007 the Beckley Foundation published its 14th 
report The effects of decriminalisation of drug use in Portugal. 
The report states that the statistical indicators suggest 
that, since decriminalisation in July 2001, there has been 
increased use of cannabis, decreased use of heroin, increased 
uptake of treatment, and reduction in drug-related deaths. 
Decriminalisation has enabled earlier intervention and more 
targeted and therapeutic responses to drug users, increased 
collaboration across a network of services, and increased 
attention to adopting policies that work. This is perceived 
to be reducing the level of current and future drug use and 
harm. Yet, key informants also reported that impacts were less 
than expected and that there were concerns over the message 
that decriminalisation was sending to new drug users. www.
idpc.ie 
In January 2008 a research study Accident & Emergency 
Nursing Assessment of Deliberate Self Harm was released 
by the HSE South and the National Suicide Research 
Foundation Ireland. It reports on a pilot study exploring ‘the 
impact of introducing a suicide education programme and 
a suicide intent scale into A&E/MAU nursing practice’. The 
study was based on the concern that inadequate assessment 
of deliberate self-harm (DSH) patients may result in failure 
to diagnose treatable underlying conditions such as alcohol 
dependence. Key fi ndings of the study were that (a) the 
provision of training was associated with a signifi cant increase 
in nurses’ confi dence in dealing with DSH patients and 
positive changes in their attitudes towards suicidal behaviour 
and its prevention, and (b) the use of a suicide intent scale is 
potentially valuable in referring DSH patients presenting at 
A&E/MAU to the appropriate service. www.nsrf.ie 
On 3 March 2008 the stimulant BZP (1-benzylpiperazine) 
became subject to ‘control measures and criminal provisions’ 
across the EU member states, following a decision by the 
European Council (Document number 6573/08: Council 
Decision on defi ning 1-benzylpiperazine (BZP) as a new 
psychoactive substance which is to be made subject to control 
measures and criminal provisions). The Council decision was 
the fi nal stage of a three-step procedure designed to respond 
to potentially threatening new psychoactive drugs in the 
EU. Ireland’s Department of Health and Children has begun 
the process of declaring BZP to be a controlled substance 
under Irish Misuse of Drugs legislation; this process will be 
completed within one year. www.consilium.europa.eu
(Compiled by Brigid Pike)
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Journal articles
The following abstracts are cited from recently published 
articles relating to the drugs situation in Ireland.
Illegal drug use, smoking and alcohol consumption in a low-
risk Irish primigravid population
Donnelly JC, Cooley SM, Walsh TA, Sarkar R, Durnea U and 
Geary MP
Journal of Perinatal Medicine 2008; 36(1): 70–72
The aim of this research was to evaluate the prevalence of 
illegal drug use, smoking and alcohol consumption in Irish 
primigravidas. 1,011 women were interviewed at their 
booking visit. A total of 23.5% (235) of women had used 
illegal drugs prior to their fi rst pregnancy, 28.9% were ex-
smokers and 27.9% were still smoking during pregnancy. A 
total of 53.9% admitted to drinking alcohol during pregnancy. 
Smokers are 2.8 times more likely to have used drugs in the 
past than non-smokers. Level of alcohol consumption appears 
to be a signifi cant predictor of drug use.
Listening to people with intellectual disabilities who misuse 
alcohol and drugs
Taggart L, McLaughlin D, Quinn B and McFarlane C
Health & Social Care in the community 2007; 15(4): 360–368
Very little research has explored alcohol/drug use and 
misuse by people with intellectual disabilities. The aims of 
the present study were twofold: (1) to examine the insights 
of 10 people with intellectual disabilities into the reasons 
why they may misuse alcohol or drugs, and what impact 
this behaviour may have on them; and (2) to explore the 
services that they receive. Ten individuals with intellectual 
disabilities who were deemed to be misusing alcohol/drugs 
were purposively selected and interviewed. One overarching 
theme of the reasons for such misuse was labelled as ‘self-
medicating against life’s negative experiences’. This was 
divided into two sub-themes: ‘psychological trauma’ and 
‘social distance from the community’. All the participants 
reported that their main source of support came from 
intellectual disability services, acting in both educational 
and liaison roles. Although seven of the individuals were 
referred to mainstream addiction services, they perceived 
this service as negative. In order to address these underlying 
problems, better access to a wider range of specialist services 
is required. Intellectual disability and mainstream addiction 
service providers also need to be more effective in the 
prevention and treatment of substance misuse by employing 
techniques such as motivational interviewing.
Opiate dependence and pregnancy: 20-year follow-up study
Whitty M and O’Connor J
Psychiatric Bulletin 2007; 31: 450–453
This study examined the 20-year outcome of 55 women who 
were pregnant and using opiates in 1985 and were attending 
the Drug Treatment Centre Board in Dublin. We established 
outcome across a number of variables, including mortality, 
psychiatric and physical morbidity, psychosocial functioning, 
ongoing drug misuse and outcome of offspring. At 20-year 
follow-up 29 women (53%) were deceased; HIV accounted 
for 17 deaths (59%). Those who were alive at follow-up 
displayed high rates of unemployment (84%) and of illicit 
substance misuse (74%), and most were dependent on state-
subsidised accommodation (78%). Mortality was higher in 
our group than in other long-term follow-up samples. These 
fi ndings suggest that such participants and their offspring 
require intensive long-term support and treatment.
Infl uence on self-rated health of socio-demographic, 
lifestyle and affl uence factors: an analysis of the Irish and 
International Health Behaviour among School-Aged Children 
(HBSC) datasets 1998
Kelleher CC, Tay J and Gabhainn SN
Irish Medical Journal 2007; 100(8): suppl. 43–46
In this analysis we employed the international Health 
Behaviour Among School Aged Children (HBSC) 1998 data, 
comprising 8,326 Irish children and 115,327 children in the 
international dataset, to examine infl uences on self-reported 
health among young people. Factors were similar for both 
boys and girls and between countries. Daily smokers, those 
reporting intoxication at least once, those taking infrequent 
exercise and those reporting diffi culty in making friends 
were all predictive of poor self-rated health in adjusted odds 
ratio models. Disposable means, as measured by the Family 
Affl uence Score was also a signifi cant predictor of self-rated 
health but not as infl uential as reported lifestyle. In a multi-
level, between-country comparison of 15 OECD countries, 
individual health behaviours explained much, but not all, of 
the variability in poor self-reported health (0.26, SE 0.08) 
and, of various ecological level indicators considered in the 
fi nal model, only % voting and % males with minimum 2nd 
level of male education in the population were infl uential 
factors, with between-country variations still not fully 
explained (0.10, SE 0.03).
Poverty, health and participation
Cosgrove S
Irish Medical Journal 2007;100(8): suppl. 73–75
Poverty is an important infl uence on health and, despite 
continuing economic growth, poverty and health inequalities 
persist. Current public policy aims to reduce the inequalities 
in health by focusing on the social factors infl uencing health, 
improving access to health and personal social services for 
those who are poor or socially excluded and by improving 
the information and research base in respect of the health 
status and service access for the poor and socially excluded 
groups. It is important that processes for target setting 
and evaluation involve people experiencing poverty, at all 
levels, through consultative and participative structures 
and processes and in the roll-out of primary care teams. A 
number of projects throughout the country aim to address 
health inequalities using community development. These are 
essentially about widening participation in the development, 
planning and delivery of health services and ensuring that 
the community is actively involved in the decision making 
process about health services in their area.
(Compiled by Louise Farragher)
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(Compiled by Louise Farragher – lfarragher@hrb.ie)
May
7–15 May 2008
Cork Drug Awareness Week 2008 
Organised by/Contact: Jacqueline Daly jdaly@partnershipcork.
ie or Mella Magee mmagee@partnershipcork.ie 
Tel: +353 (0)21 430 2310
Information: The aim of Cork Drug Awareness Week is to raise 
awareness and signpost information so that communities, 
families and professionals know where to go for assistance 
or information on drug and alcohol use. Events taking place 
include:
7–10 May 2008
Drug and Alcohol Workshops, Activities and Competitions for 
Youth Group members in out of School Settings
Venues and dates to be confi rmed.
13 May 2008
Conference: Brief Interventions to Reduce Drug & Alcohol 
Related Harm: Who, Where and When? 
Venue: Imperial Hotel, South Mall, Cork. (9.30am – 2.30pm) 
Information: Targeted at professionals, concerned individuals, 
and community representatives. Includes the launch of a multi-
lingual, locally produced leafl et Brief intervention on alcohol. 
15 May 2008
Family Information Event 
Venue: Clarion Hotel, Cork (7pm-10pm) 
Information: Accessible information evening targeted at families 
and concerned people with an interest in or affected by drug 
and alcohol misuse.
11–15 May 2008
International Harm Reduction Association 19th International 
Conference: Towards a global approach 
Venue: Palacio de Congresos, Fira de Barcelona, Spain
Organised by/Contact: International Harm Reduction 
Association (IHRA)
Tel: +44 (0) 207 462 6997
Fax: +44 (0) 207 462 6999
Email: info@ihraconferences.com 
www.ihra.net/Barcelona/Home 
Information: IHRA’s harm reduction conferences have been held 
around the world every year since 1990, and the next event 
takes place in Barcelona. Over fi ve days, this conference will be 
the main meeting point for those interested in harm reduction, 
and an invaluable platform for debate, discussion, and the 
dissemination of new and evolving good practice in addressing 
drug use and associated harm. 
21–22 May 2008 
Tabor Lodge Annual Seminar. Beyond Trauma: A healing 
Journey for Women
Venue: Carrigaline Court Hotel, Cork
Cost: €200
Organised by/Contact: Tabor Lodge
Tel: +353 (0)21 488 7110
Email: taborlodge@eircom.net 
Information: Download the booking form from www.drugs.ie/
pdf/TaborLodge.pdf 
23 May 2008
Young People, Alcohol, and Drugs: A World of Solutions
Venue: O’ Reilly Hall, University College Dublin
Organised by/Contact: Juvenile Mental Health Matters
Email: muriel.keegan@ucd.ie
www.juvenilementalhealthmatters.com
Information: This year’s conference will launch a major 
research study on alcohol use, drug use and family functioning 
conducted in Ireland with 492 young people and will invite a 
team of international experts from the UK, the US, and Australia 
to respond on evidenced based approaches to working with 
young people who use and abuse alcohol and drugs. See JMHM 
website for full details.
29–31 May 2008
EUROPAD 8 Conference
Venue: Kempinski Hotel, Sofi a, Bulgaria
Organised by/Contact: EUROPAD: European Opiate Addiction 
Treatment Association 
www.europad.org 
Information: Further details to be announced.
30 May 2008 
Harm Reduction Conference: Meeting the Challenge
Venue: Village Hotel, Swansea
Organised by/Contact: Swansea Drugs Project, 8 Calvert 
Terrace, Swansea, SA1 6AR
Tel: +44 (0) 1792 472002
Fax: +44 (0) 1792) 472004
Information: Speakers include:
Keynote Speaker: Patrick O’Hare, Geneva (International • 
perspective and overview)
Brian Gibbons, Welsh Assembly Government Minister• 
Josie Smith, National Public Health Service (HIV / • 
Hepatitis C)
Neil Hunt (Injecting rooms)• 
Julian Race (Diamorphine prescribing)• 
Andrew Preston (Harm reduction / Exchange supplies)• 
Tony Duffi n, Ana Liffey Drug Project, Dublin (Low • 
threshold – Harm reduction)
Rob Llewelyn (Harm reduction and pregnancy)• 
Michael Linnell, Lifeline ( 21 years of harm reduction • 
information)
Jayne Peters, Treatment Services Manager, Bristol Drugs • 
Project
Melanie Seddon (Alcohol and harm reduction)• 
The closing date for applications is 26 May and places are limited.
June
23–25 June 2008 
Club Health 2008. The 5th International Conference on 
Nightlife, Substance Use and Related Health Issues
Venue: Santa Eulalia, Ibiza, Spain
Organised by/Contact: Club Health 2008, Centre for Public 
Health, Liverpool John Moores University, Castle House, North 
Street, Liverpool L3 2AY, UK
Tel: +44 (0)151 231 4384
Email: k.e.hughes@ljmu.ac.uk 
www.clubhealth.org.uk 
Upcoming events
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Information: Club Health 2008 is the 5th International 
Conference on Substance Use, Nightlife and Related Health 
Issues and marks a decade of Club Health conferences. The 
event aims to promote the development of safer nightlife 
environments, and will provide an international forum for the 
exchange of experience, knowledge and practice on nightlife 
health and the management of night-time environments.
July
7–9 July 2008
Beyond 2008 Forum 
Venue: Vienna, Austria
Organised by/Contact: Vienna NGO Committee
www.vngoc.org
info@vngoc.org
Information: Beyond 2008 is a joint initiative of the Vienna and 
New York NGO Committees on drugs to facilitate an effective 
contribution from NGOs to the UNGASS Review. The target 
date of 2008 agreed at the 1998 UNGASS on Drugs for the 
achievement of ‘signifi cant and measurable results’ presents 
an opportunity for the NGO community to refl ect on its own 
achievements in drug control, exchange ideas on promising 
new approaches, reach agreements on ways to work together 
and make recommendations to multilateral agencies and UN 
member states on future directions for drug control. Building on 
past experience, the Vienna NGO Committee will host Beyond 
2008 to contribute to the 1998–2008 review and agenda-setting 
exercise being undertaken by the Commission on Narcotic 
Drugs (CND).
17–18 July 2008
Alcohol, Drugs and Criminal Justice Series: What about Harm 
Reduction?
Venue: Warwick University
Organised by/Contact: The Conference Consortium – in 
partnership with the NTA (National Treatment Agency), IHRA 
International Harm Reduction Association), DrugScope, Offender 
Health and Coventry and Warwick PCT. 
Email: warwick@conferenceconsortium.org 
www.conferenceconsortium.org 
Information: This is the third event in the ‘Alcohol, Drugs and 
Criminal Justice’ series. This conference will be returning to 
Warwick University to discuss harm reduction, what it means, how 
it applies to different fi elds of work and how it can be practically 
implemented. This promises to be an important conference at an 
important time with the launch of the new UK Drug Strategy in 
2008 and the ongoing implementation of the UK Alcohol Strategy.
This event will also report from ‘Harm Reduction 2008’, IHRA’s 
19th International Conference (Barcelona, May 2008) to highlight 
the key messages from the International Harm Reduction 
movement. The conference will focus on four different sectors and 
how they can, (and must) interact and work together to provide 
the best services: Arrests and the Courts; Prisons; Probation and 
aftercare; Alcohol and drug community treatment programmes.
October
12 October 2008
Addiction is a Choice
Venue: Herringham Hall, Regent’s College, Inner Circle, London 
NW1
Organised by/Contact: Anthony Stadlen, ‘Oakleigh’, 2A 
Alexandra Ave, London N22 7XE
Tel: +44 (0) 20 8888 6857 
E-mail: stadlen@aol.com
www.schaler.net 
Information: Professor Jeffrey A Schaler is the world’s leading 
disbeliever in ‘addiction’. He is an existential psychotherapist 
and full-time professor at American University’s School of Public 
Affairs in Washington DC. His book Addiction is a Choice (2000) 
argues that:
No drug (including alcohol and tobacco) is ‘addictive’.• 
Drugs are not intrinsically safe or dangerous, good or • 
bad.
Disease refers to cellular pathology, not behaviour.• 
‘Loss of control’ is an unfalsifi able, hence unscientifi c, • 
hypothesis.
‘Addiction’ is ethical, not medical.• 
Focusing on the existential reasons for ‘addiction’ can • 
help drug users address and resolve the problems in 
living they try to solve with drugs.
Whether you agree, disagree, or are undecided, you are 
welcome to discuss Professor Schaler’s argument and evidence 
with him at this important seminar.
Upcoming events (continued)
The Alcohol and Drug Research Unit (ADRU) of the Health 
Research Board is a multi-disciplinary team of researchers 
and information specialists who provide objective, reliable 
and comparable information on the drug situation, its 
consequences and responses in Ireland. 
The ADRU maintains two national drug-related 
surveillance systems and is the national focal point 
for the European Monitoring Centre for Drugs and 
Drug Addiction. The unit also manages the National 
Documentation Centre on Drug Use.
The ADRU disseminates research fi ndings, information 
and news through its quarterly newsletter, Drugnet 
Ireland, and other publications. Through its activities, the 
ADRU aims to inform policy and practice in relation to 
drug use.
Drugnet Ireland is published by:
Alcohol and Drug Research Unit
Health Research Board
Knockmaun House
42–47 Lower Mount Street
Dublin 2
Tel: 01 2345 127
Email: adru@hrb.ie
Managing editor: Brian Galvin
Editor: Joan Moore
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